0001493152-18-016013.txt : 20181114 0001493152-18-016013.hdr.sgml : 20181114 20181114151450 ACCESSION NUMBER: 0001493152-18-016013 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 49 CONFORMED PERIOD OF REPORT: 20180930 FILED AS OF DATE: 20181114 DATE AS OF CHANGE: 20181114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: alpha-En Corp CENTRAL INDEX KEY: 0001023298 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-ALLIED TO MOTION PICTURE PRODUCTION [7819] IRS NUMBER: 954622429 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-12885 FILM NUMBER: 181183071 BUSINESS ADDRESS: STREET 1: 10 WEST 66TH STREET CITY: NEW YORK STATE: NY ZIP: 10023 BUSINESS PHONE: 2127693814 MAIL ADDRESS: STREET 1: 10 WEST 66TH STREET CITY: NEW YORK STATE: NY ZIP: 10023 FORMER COMPANY: FORMER CONFORMED NAME: AVENUE ENTERTAINMENT GROUP INC /DE/ DATE OF NAME CHANGE: 19971103 10-Q 1 form10-q.htm

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE QUARTERLY PERIOD ENDED: September 30, 2018

 

[  ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

FOR THE TRANSITION PERIOD FROM ________ TO ________

 

Commission File Number: 000-12885

 

alpha-En Corporation

(Exact name of registrant as specified in its charter)

 

Delaware   95-4622429
(State or other jurisdiction of   (I.R.S. Employer
incorporation or organization)   Identification No.)

 

28 Wells Avenue, 2nd Floor, Yonkers, New York 10701

(914) 418-2000

(Address and telephone number of principal executive offices)

 

Indicate by check mark whether the issuer (1) filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes [X] No [  ]

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or such shorter period that the registrant was required to submit such files). Yes [X] No [  ]

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a small reporting company or an emerging growth company. See definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer [  ]   Accelerated filer [  ]
Non-accelerated filer [  ] Smaller reporting company [X]
      Emerging growth company [  ]

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accountings standards provided pursuant to Section 13)a_ of the Exchange Act. [  ]

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes [  ] No [X]

 

As of November 13, 2018, there were 39,044,589 shares of common stock outstanding.

 

 

 

   
 

 

TABLE OF CONTENTS

 

    Page
  PART I. FINANCIAL INFORMATION  
     
Item 1. Condensed Financial Statements 3
     
  Condensed Balance Sheets at September 30, 2018 (Unaudited) and December 31, 2017 3
     
  Condensed Statements of Operations for the Three and Nine Months Ended September 30, 2018 and 2017 (Unaudited) 4
     
  Condensed Statement of Stockholders’ Deficit for the Nine Months Ended September 30, 2018 (Unaudited) 5
     
  Condensed Statements of Cash Flows for the Nine Months Ended September 30, 2018 and 2017 (Unaudited) 6
     
  Notes to Condensed Financial Statements (Unaudited) 7
     
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations 15
     
Item 3. Quantitative and Qualitative Disclosures About Market Risk 18
     
Item 4. Controls and Procedures 18
     
  PART II. OTHER INFORMATION  
     
Item 1. Legal Proceedings 19
     
Item 1A. Risk Factors 19
     
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds 19
     
Item 3. Defaults Upon Senior Securities 19
     
Item 4. Mine Safety Disclosures 19
     
Item 5. Other Information 19
     
Item 6. Exhibits 19
     
 

SIGNATURES

20

 

 2 
 

 

PART I. FINANCIAL INFORMATION

 

Item 1. Financial Statements

 

ALPHA-EN CORPORATION

CONDENSED BALANCE SHEETS

(in thousands, except share and per share data)

 

    September 30,     December 31,  
    2018     2017  
    (Unaudited)        
ASSETS                
Current assets                
Cash   $ 1,064     $ 562  
Restricted cash     15       15  
Total current assets     1,079       577  
                 
 Long-term deposit     35       35  
 Property and equipment, net     665       501  
Total assets   $ 1,779     $ 1,113  
                 
LIABILITIES AND STOCKHOLDERS’ DEFICIT AND TEMPORARY EQUITY                
Current liabilities                
Accounts payable and accrued expenses   $ 617     $ 1,103  
Advances from related parties     36       308  
Current portion of deferred rent     9       -  
Total current liabilities     662       1,411  
                 
Deferred rent     109       -  
                 
Total liabilities     771       1,411  
                 
Preferred stock par value $0.01: 5,000,000 shares authorized; 4,105 shares and 1,935 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively; aggregate liquidation preference of $4,105 and $1,935 as of September 30, 2018 and December 31, 2017, respectively     4,105       1,935  
                 
COMMITMENTS AND CONTINGENCIES                
                 
Stockholders’ deficit:                
Class B common stock no par value: 1,000,000 shares authorized; none issued or outstanding     -       -  
Common stock par value $0.01: 57,000,000 shares authorized; 39,044,589 shares and 33,350,506 shares issued and 38,329,839 shares and 32,635,756 shares outstanding at September 30, 2018 and December 31, 2017, respectively     390       334  
Additional paid-in capital     21,301       18,482  
Treasury stock at cost: 714,750 shares as of September 30, 2018 and December 31, 2017     (69 )     (69 )
Accumulated deficit     (24,719 )     (20,276 )
Stockholders’ deficit attributed to alpha-En Corporation stockholders     (3,097 )     (1,529 )
Non-controlling interest     -       (704 )
Total stockholders’ deficit     (3,097 )     (2,233 )
TOTAL LIABILITIES AND STOCKHOLDERS’ DEFICIT AND TEMPORARY EQUITY   $ 1,779     $ 1,113  

 

See notes to condensed financial statements.

 

 3 
 

 

ALPHA-EN CORPORATION

CONDENSED STATEMENTS OF OPERATIONS

(in thousands, except share and per share data)

(Unaudited)

 

    For the Three Months Ended September 30,     For the Nine Months Ended
September 30,
 
    2018     2017     2018     2017  
Operating expenses                                
General and administrative   $ 1,213     $ 1,751     $ 3,396     $ 3,188  
Legal and professional fees     103       135       364       390  
Research and development (includes stock based compensation of $(28) and $(245) for the three and nine months ended September 30, 2018, and $243 and $783 for the three and nine months ended September 30, 2017, respectively. See Note 7)     372       473       837       1,093  
Total operating expenses     1,688       2,359       4,597       4,671  
                                 
Other income (loss)                                
Loss on extinguishment of accounts payable     -       (82 )     -       (82 )
Other expenses     (2 )     -       (2 )     -  
Interest income     1       1       1       1  
Total other loss     (1 )     (81 )     (1 )     (81 )
Net loss     (1,689 )     (2,440 )     (4,598 )     (4,752 )
Less: net loss attributable to non-controlling interest     -       (125 )     (155 )     (250 )
Net loss attributable to controlling interest     (1,689 )     (2,315 )     (4,443 )     (4,502 )
Less: Dividends accrued on preferred stock     (100 )     (46 )     (275 )     (68 )
Less: Deemed dividend on Series A preferred stock     -       -       (687 )     (649 )
Less: Deemed dividend - beneficial conversion feature on preferred stock     -       -       (956 )     (807 )
Net loss attributable to alpha-En Corporation common stockholders   $ (1,789 )   $ (2,361 )   $ (6,361 )   $ (6,026 )
                                 
Net loss per share attributable to alpha-En Corporation common stockholders                                
Basic and diluted   $ (0.05 )   $ (0.07 )   $ (0.18 )   $ (0.18 )
                                 
Weighted average shares outstanding:                                
Basic and diluted     35,890,676       33,337,722       35,693,698       33,300,837  

 

See notes to condensed financial statements.

 

 4 
 

 

ALPHA-EN CORPORATION

CONDENSED STATEMENT OF STOCKHOLDERS’ DEFICIT

(in thousands, except share and per share data)

(Unaudited)

 

    Common Stock     Additional
Paid-In
    Treasury Stock     Accumulated     Noncontrolling     Total Stockholders’  
    Shares     Amount     Capital     Shares     Amount     Deficit     Interest     Deficit  
Balance at December 31, 2017     33,350,506     $ 334     $ 18,482       714,750     $ (69 )   $ (20,276 )   $ (704 )   $ (2,233 )
Stock based compensation     -       -       1,932       -       -       -       -       1,932  
Shares issued for acquiring ownership of subsidiary     3,018,190       30       (889 )     -       -       -       859       -  
Issuance of common stock for cash in a private placement     1,534,433       15       1,785       -       -       -       -       1,800  
Preferred stock converted to common stock     31,460       -       55       -       -       -       -       55  
Options exercised for cash     110,000       1       21       -       -       -       -       22  
Warrants exercised for cash     1,000,000       10       190       -       -       -       -       200  
Issuance of warrants to purchase common stock associated with preferred stock offering     -       -       687       -       -       -       -       687  
Deemed dividend on Series A preferred stock     -       -       (687 )     -       -       -       -       (687 )
Beneficial conversion feature of Series A preferred stock     -       -       956       -       -       -       -       956  
Deemed dividends related to beneficial conversion feature of Series A preferred stock     -       -       (956 )     -       -       -       -       (956 )
Accrued Series A dividends     -       -       (275 )     -       -       -       -       (275 )
Net loss     -       -       -       -       -       (4,443 )     (155 )     (4,598 )
Balance at September 30, 2018     39,044,589     $ 390     $ 21,301       714,750     $ (69 )   $ (24,719 )   $ -     $ (3,097 )

 

See notes to condensed financial statements.

 

 5 
 

 

ALPHA-EN CORPORATION

CONDENSED STATEMENTS OF CASH FLOWS

(in thousands)

(Unaudited)

 

    For the Nine Months Ended September 30,  
    2018     2017  
Cash flows from operating activities                
Net loss   $ (4,598 )   $ (4,752 )
                 
Adjustments to reconcile net loss to net cash used in operating activities:                
Depreciation and amortization     83       41  
Stock-based compensation     1,932       2,706  
Warrant issued for services     -       249  
Loss on extinguishment of accounts payable     -       82  
Changes in operating assets and liabilities of business, net of acquisitions:                
Prepaid expenses     -       2  
Accounts payable and accrued expenses     (553 )     62  
Deferred rent     118       -  
Net cash used in operating activities     (3,018 )     (1,610 )
                 
Cash flows from investing activities                
Release of restricted cash and long term deposit     -       100  
Purchase of fixed assets     (180 )     (25 )
Net cash (used in) provided by investing activities     (180 )     75  
                 
Cash flows from financing activities                
Proceeds from issuance of preferred stock and warrants     1,700       1,670  
Proceeds from issuance of common stock in a private placement     1,800       -  
Options exercised for cash     22       -  
Warrants exercised for cash     200       -  
Advances from related parties     -       150  
Repayments of advances from related parties     (22 )     (42 )
Net cash provided by financing activities     3,700       1,778  
                 
Net increase in cash     502       243  
Cash and restricted cash at beginning of period     562       442  
Cash and restricted cash at end of period   $ 1,064     $ 685  
                 
Non cash financing and investing activities:                
Beneficial conversion feature of Series A preferred stock   $ 956     $ 807  
Deemed dividends related to beneficial conversion feature of Series A preferred stock   $ (956 )   $ (807 )
Issuance of warrants in preferred stock offering   $ 687     $ 649  
Deemed dividend on Series A preferred stock   $ (687 )   $ (649 )
Accrued Series A dividends   $ (275 )   $ (68 )
Conversion of advances from related parties to preferred stock   $ 250     $ 150  
Common stock and warrants issued for extinguishment of accounts payable   $ -     $ 192  
Preferred stock converted to common stock   $ 55     $ -  
Purchases of fixed assets in accounts payable   $ 67     $ -  
Forgiveness of the lease payments   $ 104     $ -  

 

See notes to condensed financial statements.

 

 6 
 

 

Note 1 - Organization and Operations

 

alpha-En Corporation (the “Company”) was incorporated in Delaware on March 7, 1997.

 

Since 2008, the focus of the Company’s business has been developing new technologies for manufacturing highly pure lithium metal, a raw material for use in lightweight, high energy density batteries, in an environmentally friendly manner for commercial purposes. In 2013, the Company invented a new process for the production of highly pure lithium metal and associated products at room temperature. The Company subsequently broadened its focus to develop products and processes derived from the Company’s new core proprietary technology, including battery components and compounds of lithium.

 

Ownership of Subsidiary

 

In September 2014, alpha-En Corporation formed Clean Lithium Corporation (“CLC”) under the laws of New York State as a wholly owned subsidiary with a nominal share capital of $100,000. From 2014 to 2016, the Company sold 9.05% or 905,000 of CLC’s shares to minority equity holders. Effective as of June 14, 2018, the Company completed the purchase all of the outstanding shares of CLC such that CLC became a wholly-owned subsidiary of the Company and was immediately thereafter merged with and into the Company, with the Company surviving. In connection with this transaction, the former minority equity holders of CLC prior to the merger received an aggregate total of 3,018,190 shares of common stock of the Company. The Company recorded the acquisition of CLC as a capital transaction.

 

Amended and Restated Certificate of Incorporation

 

On March 29, 2017 the Board of Directors of the Company and a subset of the Company’s stockholders representing in excess of 75% of the Company’s currently issued and outstanding voting stock approved of the amendment and restatement of the Company’s Certificate of Incorporation (the “Restated Certificate”) to make certain corporate governance updates and to increase the authorized capital stock of the Company to 60,000,000 shares, of which 57,000,000 are shares of Common Stock, par value $0.01 per share, 1,000,000 are shares of Class B Common Stock, par value $0.01 per share and 2,000,000 are shares of preferred stock, par value $0.01 per share. The Company filed a definitive information statement on Schedule 14C with the Securities and Exchange Commission on June 1, 2017 describing the changes in the Restated Certificate. The Restated Certificate was filed with the Secretary of State for the State of Delaware and became effective on June 30, 2017. On February 8, 2018 the Company filed with the Secretary of State of the State of Delaware an amended and restated certificate of incorporation increasing the authorized number of preferred shares designated as series A preferred from 2,000 to 5,000.

 

Note 2 - Going Concern and Liquidity

 

The Company’s condensed financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

 

As reflected in the condensed financial statements, the Company had an accumulated deficit of approximately $24.7 million at September 30, 2018, a net loss of approximately $4.6 million and approximately $3.0 million net cash used in operating activities for the nine months ended September 30, 2018. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company is attempting to further develop the intellectual property associated with its technology; broaden its patent portfolio; scale up its production of various products; and begin generating revenue; however, the Company’s cash position is not sufficient to support its daily operations for the foreseeable future. The ability of the Company to continue as a going concern is dependent upon its ability to raise additional funds by way of a public or private offering and its ability to further develop its technology and generate sufficient revenue. While the Company believes in the viability of its technology and in its ability to raise additional funds by way of a public or private offering, there can be no assurances to that effect.

 

The condensed financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

 7 
 

 

Note 3 - Significant and Critical Accounting Policies and Practices

 

Basis of Presentation and Principles of Consolidation

 

On June 14, 2018 the Company completed the purchase all of the outstanding shares of CLC such that CLC became a wholly-owned subsidiary of the Company and was immediately thereafter merged with and into the Company, with the Company surviving. Accordingly, as of June 14, 2018 the Company no longer has any subsidiaries consolidated in these financial statements.

 

For the year ended December 31, 2017 and through June 14, 2018, the accompanying condensed consolidated financial statements include the accounts of the Company’s subsidiaries. For consolidated entities where the Company owns less than 100% of the subsidiary, the Company records net loss attributable to non-controlling interests in its condensed consolidated statements of operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties.

 

The condensed consolidated balance at December 31, 2017 was derived from audited annual financial statements but do not contain all of the footnote disclosures from the annual financial statements. The unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments (consisting of normal recurring adjustments unless otherwise indicated) which, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented.

 

Certain information in footnote disclosures normally included in the financial statements prepared in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the SEC rules and regulations for interim reporting. The financial results for the periods presented may not be indicative of the full year’s results.

 

These unaudited condensed financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2017 included in the Company’s Annual Report on Form 10-K filed on April 2, 2018.

 

Use of Estimates

 

The Company’s condensed financial statements include certain amounts that are based on management’s best estimates and judgments. The Company’s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, fair value used in estimating the value of warrants, stock-based compensation, accrued expenses and provisions for income taxes. Due to the uncertainty inherent in such estimates, actual results may differ from these estimates.

 

Cash

 

As of September 30, 2018 and December 31, 2017, substantially all of the Company’s cash was held by major financial institutions and the balance at certain times may exceed the maximum amount insured by the Federal Deposits Insurance Corporation. However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.

 

Property and Equipment

 

Lab equipment, leasehold improvements and office equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of each asset, generally three to seven years.

 

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. There were no indicators of impairment for long-lived assets during the nine months ended September 30, 2018.

 

Fair Value of Preferred Stock

 

The fair value of Preferred stock was estimated based upon equivalent common shares that Preferred Stock could have been converted into at the closing price on the purchase date.

 

 8 
 

 

Convertible Financial Instruments

 

The Company bifurcates conversion options from their host instruments and accounts for them as free standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.

 

When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument. Deemed dividends are also recorded for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.

 

Research and Development

 

Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. Upfront and milestone payments due to third parties that perform research and development services on the Company’s behalf will be expensed as services are rendered or when the milestone is achieved.

 

Research and development costs primarily consist of personnel related expenses, including salaries, benefits, travel, and other related expenses, stock-based compensation, payments made to third parties for license and milestone costs related to in-licensed products and technology, payments made to third party contract research organizations, consultants, the cost of acquiring and manufacturing research trial materials, and costs associated with regulatory filings, laboratory costs and other supplies.

 

In accordance with ASC 730-10-25-1, Research and Development, costs incurred in obtaining technology licenses are charged to research and development expense if the technology licensed has not reached commercial feasibility and has no alternative future use. Certain licenses purchased by the Company require substantial completion of research and development and regulatory and marketing approval efforts in order to reach commercial feasibility and have no alternative future use.

 

During the nine months ended September 30, 2018, in addition to ongoing efforts at one major research university, the Company entered into additional contracts with a national research lab and another major research university for additional work related to development and scale-up of the Company’s processes. The Company also commenced research and development efforts at the Company’s Yonkers lab facility.

 

Contingencies

 

The Company records accruals for contingencies and legal proceedings expected to be incurred in connection with a loss contingency when it is probable that a liability has been incurred and the amount can be reasonably estimated.

 

If a loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.

 

Stock-Based Compensation

 

The Company expenses stock-based compensation to employees over the requisite service period based on the estimated grant-date fair value of the awards. For stock-based compensation awards to non-employees, the Company remeasures the fair value of the non-employee awards at each reporting period prior to vesting and finally at the vesting date of the award. Changes in the estimated fair value of these non-employee awards are recognized as compensation expense in the period of change.

 

The Company estimates the fair value of stock options grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment.

 

 9 
 

 

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

 

Loss Per Share

 

Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share excludes the potential impact of common stock options, convertible preferred stock and outstanding common stock purchase warrants because their effect would be anti-dilutive.

 

Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows:

 

    As of September 30,  
    2018     2017  
Warrants to purchase common stock     4,719,292       4,744,292  
Options to purchase common stock     16,024,000       8,880,000  
Preferred stock convertible into common stock     2,348,060       -  
Total     23,091,352       13,624,292  

 

Non-Controlling Interests

 

Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third parties. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests.

 

Recent Accounting Pronouncements

 

The Company considers the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not discussed below were assessed and determined to be either not applicable or are expected to have minimal impact on our balance sheets or statements of operations.

 

In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-13, “Fair Value Measurement (Topic 820), – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement,” which makes a number of changes meant to add, modify or remove certain disclosure requirements associated with the movement amongst or hierarchy associated with Level 1, Level 2 and Level 3 fair value measurements. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the update. The Company is still evaluating but does not expect the adoption of this guidance to have a material impact on its condensed Financial Statements.

 

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company plans to adopt this change in Q1 2019.

 

In June 2018, the FASB issued ASU 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The changes take effect for public companies for fiscal years starting after December 15, 2018, including interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity’s adoption date of Topic 606. We are still evaluating but expect the adoption of this pronouncement will eliminate significant fluctuation in stock based compensation expensed in the past due to awards to non-employees.

 

 10 
 

 

In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception, (ASU 2017-11). Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company is currently assessing the potential impact of adopting ASU 2017-11 on its financial statements and related disclosures.

 

In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting, (ASU 2017-09). ASU 2017-09 provides clarity and reduces both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, to a change to the terms or conditions of a share-based payment award. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company adopted this ASU on January 1, 2018 and the adoption did not have a material impact on the Company’s financial position or results of operations.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) and subsequent amendments to the initial guidance: ASU 2017-13, ASU 2018-10 and ASU 2018-11 (collectively, Topic 842). Topic 842 requires companies to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. Topic 842 is effective for us in our first quarter of fiscal 2020, and earlier adoption is permitted. We are currently evaluating the impact of our pending adoption of Topic 842 on our consolidated financial statements. We currently expect that most of our operating lease commitments (see MD&A for commitments) will be subject to the new standard and recognized as operating lease liabilities and right-of-use assets upon our adoption of Topic 842, which will increase our total assets and total liabilities that we report relative to such amounts prior to adoption.

 

In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases which clarifies, corrects or consolidates authoritative guidance issued in ASU 2016-02 and is effective upon adoption of ASU 2016-02. In July 2018, the FASB issued ASU 2018-11, Targeted Improvements, which provides an optional transition method that allows entities to elect to apply the standard prospectively at its effective date, versus recasting the prior periods presented. If elected, an entity would recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. The Company is still evaluating the method of adopting the standard.

 

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company adopted the standard as of January 1, 2018 and adoption did not have a material impact on its condensed statement of cash flows.

 

Note 4 - Property and Equipment

 

The components of property and equipment as of September 30, 2018 and December 31, 2017, at cost are (dollars in thousands):

 

    Useful Life (Years)     September 30, 2018     December 31, 2017  
Lab equipment     3     $ 415     $ 173  
Office furniture and equipment     3       31       31  
Leasehold improvement     7       379       374  
Gross property and equipment             825       578  
Less: Accumulated depreciation and amortization             (160 )     (77 )
Property and equipment, net           $ 665     $ 501  

 

The Company’s depreciation and amortization expense for the three and nine months ended September 30, 2018 was $32,000 and $83,000, and $24,000 and $41,000 for the three and nine months ended September 30, 2017, respectively.

 

 11 
 

 

Note 5 - Related Party Transactions

 

Advances from Stockholders

 

From time to time, stockholders of the Company advances funds to the Company for working capital purposes. Those advances are unsecured, non-interest bearing and due on demand.

 

As of September 30, 2018 and December 31, 2017, the outstanding amounts of the advances from related parties was approximately $36,000 and $308,000, respectively. During the nine months ended September 30, 2018, the Company repaid $15,000 in advances to Jerome Feldman and $7,000 to Steven Fludder and $250,000 was converted into preferred stock. See Note 6 for more details on advances converted to preferred stock.

 

Employment Agreement with Chief Executive Officer

 

On November 11, 2017, the Company appointed Sam Pitroda to serve as the Company’s new Chief Executive Officer. Since that time, Mr. Pitroda has served as CEO without an employment agreement. The Company and Mr. Pitroda are in discussions to finalize the terms of the employment agreement, although there can be no assurances that an agreement will be reached. On May 31, 2018, the board of directors approved to grant Mr. Pitroda an option to purchase 7,000,000 shares of the Company’s common stock at an exercise price of $2.08 per share. The option expires seven years from the option grant date. The stock subject to the option will vest upon the earlier to occur of (1) the five-year anniversary of the option grant date or (2) the achievement of certain stock price and volume milestones, which are as follows:

 

    For 20 consecutive business 

Total option shares that

Common stock price   days, with average daily  become vested on satisfaction
closes at or above   volumn in excess of  of conditions
$3.00   20,000  2,000,000 (28.5%)
$6.00   40,000  4,000,000 (51.7%)
$11.00   60,000  7,000,000 (100.0%)

 

The total fair value of this option award on the grant date was approximately $7.6 million. The fair value of the option award was determined using the Black-Scholes model with the following assumptions: risk free interest rate – 2.7%, volatility – 78.0%, expected term – 4 years and dividends– N/A. The Company will amortize the option over its service period of 4.09 years which was derived from a Monte Carlo simulation. Stock-based compensation expense for this option recognized for the three and nine months ended September 30, 2018 was $466,000 and $622,000, respectively.

 

On September 1 2017, Steven Fludder, former CEO, resigned from the Company. On June 22, 2018, the Company vested 150,000 stock options that would have been forfeited. The Company recorded additional stock compensation expense of $210,000 related to this stock option modification.

 

Note 6 - Temporary Equity

 

The following table summarizes the Company’s Series A Preferred Stock activities for the nine months ended September 30, 2018 (dollars in thousands):

 

    Series A Preferred Stock  
    Shares     Amount  
Total temporary equity as of December 31, 2017     1,935     $ 1,935  
Sale of Series A preferred stock     1,700       1,700  
Conversion of advances into preferred stock     250       250  
Preferred stock converted to common stock     (55 )     (55 )
Beneficial conversion feature of Series A preferred stock     -       (956 )
Deemed dividends related to beneficial conversion feature of Series A preferred stock     -       956  
Accrued Series A dividends     275       275  
Deemed dividend on Series A preferred stock     -       687  
Fair Value of common stock warrant issued with Series A preferred stock     -       (687 )
Total temporary equity as of September 30, 2018     4,105     $ 4,105  
                 

 

 12 
 

 

On February 8, 2018, the Company entered into a preferred stock purchase agreement (“Stock Purchase Agreement”) with several accredited and institutional investors, pursuant to which the Company agreed to issue and sell in a private placement 1,950 shares of Series A Preferred Stock, as well as 975,000 warrants to purchase the Company’s common stock, at a purchase price of $1,000 per share, for total gross proceeds of $1.95 million (including previous advances from related parties). The warrants have a 5-year term and an exercise price of $2.00. Steven M. Payne converted $100,000, Jerome I. Feldman converted $50,000 and Jim Kilman through KielStrand Capital LLC converted $100,000 advances into preferred stock. Sam Pitroda through Pitroda Group LLC invested $500,000 and the Company issued 500 Series A Preferred Stock and 250,000 warrants on the same terms as other accredited and institutional investors.

 

The Series A Preferred is entitled to accrue cumulative dividends at a rate equal to 10.0% simple interest per annum on the original issue price of $1,000 per share (the “Original Issue Price”). Accrued dividends will be payable quarterly based on a 365-day year and may be paid in cash or in additional shares of Series A Preferred. Each share of Series A Preferred is convertible into 572 shares of Common Stock, subject to customary increases or decreases for stock splits, stock dividends recapitalizations and the like, and may be converted to Common Stock at any time after issuance at the option of a holder. The Company will have the right, at the Company’s option, to redeem all or a portion of the shares of Series A Preferred Stock at any time or times after the one year anniversary of the Issuance Date of such Series A Preferred Stock, at a price per share (the “Redemption Price”) equal to the sum of the following (without duplication): (a) the Original Issue Price, plus (b) any accrued but unpaid Dividends. Upon any liquidation, dissolution or winding up of the Company, liquidation of the Company’s assets will be made in the following order of priority: (a) first, payment or provision for payment of debts and other liabilities; (b) second, payment to the holders of Series A Preferred an amount with respect to each share of Series A Preferred equal to the Original Issue Price, plus any accrued but unpaid Dividends thereon; and (c) third, payment to the holders of Common Stock. Except as required by applicable law or as set forth herein, the holders of shares of Series A Preferred Stock will vote together with the holders of shares of Common Stock and not as a separate class. Each share of Series A Preferred Stock will have a number of votes equal to the number of shares of Common Stock then issuable upon conversion of such share of Series A Preferred Stock.

 

The Series A Preferred Stock is being classified as temporary equity because it has redemption features that are outside of the Company’s control upon certain triggering events, such as a deemed liquidation event. A “Deemed Liquidation Event” is defined in the Company’s Amended and Restated Certificate of Incorporation as a merger that results in a change in control or the sale of substantially all the assets of the Company. In the case of a Deemed Liquidation Event, the assets of the Company will be paid in order of liquidation preference to the holders of preferred and common stock. Because certain holders of the Series A Preferred Stock constitute a majority of the Company’s Board of Directors, a potential Deemed Liquidation Event is considered to be outside the control of the Company along with the call provision that can be exercised in one year, resulting in classification of the Series A Preferred Stock as temporary equity.

 

The Company has determined that the warrants should be accounted as a component of stockholders’ equity. On the issuance date, the Company estimated the fair value of the warrants at $1.2 million using the Black-Scholes option pricing model using the following primary assumptions: contractual term of 5.0 years, volatility rate of 74.8%, risk-free interest rate of 2.57% and expected dividend rate of 0%. Based on the warrant’s relative fair value to the fair value of the Series A Preferred, approximately $687,000 of the $1.2 million of aggregate fair value was allocated to the warrants, creating a corresponding preferred stock discount in the same amount.

 

Due to the reduction of allocated proceeds to Series A Preferred, the effective conversion price was approximately $1.13 per share creating a beneficial conversion feature of $956,000 which reduced the carrying value of the Series A Preferred. Since the conversion option of the Series A Preferred was immediately exercisable, the beneficial conversion feature was immediately accreted to preferred dividends, resulting in an increase in the carrying value of the Series A Preferred.

 

During nine months ended September 30, 2018, there were 55 shares of preferred stock converted into 31,460 shares of common stock. As of September 30, 2018, the dividends accrued and outstanding were $385,000 and reflected in carrying value of temporary equity.

 

Note 7 - Stockholders’ (Deficit) Equity

 

Common Stock

 

On March 21, 2018, the Company entered into a private placement offering with an investor and issued 826,446 shares of its common stock for $1.0 million. In addition, the Company granted this investor the non-exclusive rights to distribute its product in China for a period of two years. In connection with this private placement, the Company issued 41,322 shares of common stock to an investor as a finder’s fee.

 

On August 23, 2018, the Company entered into a private placement offering with three investors and issued 666,665 shares of its common stock for $800,000.

 

 13 
 

 

Stock Options

 

The fair value of the Company’s common stock was based upon the publicly quoted price on the date that the final approval of the awards was obtained. The Company does not expect to pay dividends in the foreseeable future so therefore the expected dividend yield is 0%. The expected term for stock options granted with service conditions represents the average period the stock options are expected to remain outstanding and is based on the expected term calculated using the approach prescribed by the Securities and Exchange Commission’s Staff Accounting Bulletin for “plain vanilla” options. The expected term for stock options granted with performance and/or market conditions represents the period estimated by management by which the performance conditions will be met. The Company obtained the risk-free interest rate from publicly available data published by the Federal Reserve. The Company uses a methodology in estimating its volatility percentage from a computation that was based on a comparison of average volatility rates of similar companies to a computation based on the standard deviation of the Company’s own underlying stock price’s daily logarithmic returns. The grant date fair value of stock options granted during the nine months ended September 30, 2018 and 2017 was $8.4 million and $4.6 million, respectively. The fair value of options granted during the nine months ended September 30, 2018 and 2017 were estimated using the following weighted-average assumptions:

 

    For the Nine Months Ended September 30,  
    2018     2017  
Exercise price   $ 2.05     $ 1.85  
Expected stock price volatility     78 %     79 %
Risk-free rate of interest     2.68 %     1.61 %
Term (years)     4.0       3.1  

 

A summary of option activity under the Company’s employee stock option plan for the nine months ended September 30, 2018 is presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2017     5,669,000     $ 1.48     $ 7,793,000       4.3  
Employee options granted     7,610,000       2.06       19,000       6.5  
Exercised     (100,000 )     0.20       152,000       -  
Expired     (250,000 )     0.10       443,000       -  
Outstanding as of September 30, 2018     12,929,000     $ 1.85     $ 1,649,000       5.4  
Options vested and expected to vest as of September 30, 2018     12,929,000     $ 1.85     $ 1,649,000       5.4  
Options vested and exercisable as of September 30, 2018     3,336,500     $ 1.51     $ 1,185,000       3.9  

 

Estimated future stock-based compensation expense relating to unvested employee stock options is approximately $8.3 million as of September 30, 2018 and will be amortized over 4.0 years.

 

A summary of activity of options granted to non-employees for the nine months ended September 30, 2018 is presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2017     3,205,000     $ 0.40     $ 7,847,000       2.4  
Non-employee options granted     200,000       1.64       22,000       4.0  
Exercised     (10,000 )     0.20       22,000       -  
Expired     (300,000 )     0.15       491,000       -  
Outstanding as of September 30, 2018     3,095,000     $ 0.51     $ 3,767,000       2.0  
Options vested and expected to vest as of September 30, 2018     3,095,000     $ 0.51     $ 3,767,000       2.0  
Options vested and exercisable as of September 30, 2018     2,582,500     $ 0.47     $ 3,223,000       1.9  

 

 

Warrants

 

A summary of the status of the Company’s outstanding warrants as of September 30, 2018 and changes during the nine months then ended is presented below:

 

    Number of Warrants     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2017     4,744,292     $ 1.24     $ 7,884,000       3.6  
Issued     975,000       2.00       -       4.4  
Exercised     (1,000,000 )     0.20       1,680,000       -  
Outstanding as of September 30, 2018     4,719,292     $ 1.62     $ 1,830,000       3.3  
Warrants exercisable as of September 30, 2018     4,469,292     $ 1.64     $ 1,705,000       3.2  

 

Stock-based Compensation Expense

 

Stock-based compensation expense for the nine months ended September 30, 2018 and 2017 was comprised of the following (dollars in thousands):

 

    For the Three Months Ended September 30,     For the Nine Months Ended September 30,  
    2018     2017     2018     2017  
Employee stock option awards   $ 862     $ 1,367     $ 2,250     $ 1,723  
Non-employee option awards     (22 )     273       (318 )     983  
Total compensation expense   $ 840     $ 1,640     $ 1,932     $ 2,706  

 

 14 
 

 

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

 

CAUTIONARY STATEMENT PURSUANT TO THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995

 

Certain statements contained in this report on Form 10-Q constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Forward-looking statements give expectations or forecasts of future events. Forward-looking statements can be identified by words such as “believe,” “expect,” “anticipate,” “estimate,” “project,” “plan,” “should,” “intend,” “may,” “will,” “would,” “potential” and similar expressions to future periods. Forward-looking statements are not based on historical facts but rather represent current expectations and assumptions. Forward-looking statements include statements we make about matters such as: future revenues; future industry conditions; future changes in our capacity and operations; research and development and capital expenditures and their impact on us; business process, rationalization, investment, operational, tax, financial and capital projects and initiatives; contingencies; changes in the regulatory environment; future capital raising activities and future working capital, costs, revenues, business opportunities, cash flows, margins, earnings and growth.

 

Forward-looking statements relate to the future and are subject to many risks, assumptions and uncertainties, including those risks set forth in this report and as described in Part I, Item IA Risk Factors of our Annual Report on Form 10-K for our prior fiscal year ended December 31, 2017. Although we believe the expectations reflected in the forward-looking statements are reasonable, actual results, developments and business decisions could differ materially from those contemplated by such forward-looking statements. The environment for which we operate in is highly competitive and rapidly changing and it is not possible for our management to predict all risks, as new risks emerge from time to time.

 

While no list of uncertainties could be complete, some factors that could cause actual results to differ materially from those in the forward-looking statements include the following, without limitation: current and future business and economic uncertainties may adversely affect our ability to generate revenues, profitability and financial condition; changes in the energy storage and battery markets could adversely affect our ability to compete and or to successfully commercialize products acceptable to the market; our business, financial condition and results of operations could be adversely affected by new government regulations; potential inability to attract and retain skilled personnel, could harm our business; we may pursue strategic opportunities which could result in operating difficulties or dilution; assertions of claims, lawsuits and proceedings against us could harm our business, results of operations and reputation; and our potential inability to raise capital when and if needed.

 

All subsequent written and oral forward-looking statements by or attributable to us or persons acting on our behalf are expressly qualified in their entirely by these factors. We undertake no obligation to publicly update or revise any forward-looking statements whether as a result of new information, future developments or otherwise, except as may be required by law.

 

Overview

 

Since 2008, we have been focused exclusively on efforts to develop a business centered around the commercial manufacturing of highly pure lithium metal, a raw material for use in lightweight, high energy density batteries, in an environmentally friendly manner. Additionally, we have broadened our focus to include lithium products and processes derived from our core technology. This includes battery components such as protected anodes and compounds of lithium, among other things.

 

Lithium is the lightest metal with the highest electrochemical potential, making it a clear choice for batteries. There is a substantial existing market for lithium metal in primary (non-rechargeable) batteries, and rechargeable batteries, including many future opportunities which exist for next-generation batteries under development.

 

We have no revenues and our business is in the development stage. Our operations primarily include activities related to developing our technology and maintaining our public company status.

 

During the nine months ended September 30, 2018, in addition to ongoing efforts at one major research university, we entered into additional contracts with a national research lab and another major research university for additional work related to development and scale-up of our processes. We also commenced research and development efforts at our Yonkers lab facility.

 

Results of Operations

 

Three Months Ended September 30, 2018 Compared to Three Months Ended September 30, 2017

 

 15 
 

 

General and administrative expenses were approximately $1.2 million for the three months ended September 30, 2018 as compared to approximately $1.8 million for the three months ended September 30, 2017. The decrease in general and administrative expenses mostly relates to stock-based compensation and warrants issued for services which were approximately $869,000 and $1.5 million for the three months ended September 30, 2018 and 2017, respectively.

 

Legal and professional fees were approximately $103,000 for the three months ended September 30, 2018 as compared to approximately $135,000 for the three months ended September 30, 2017.

 

Research and development expenses were approximately $372,000 for the three months ended September 30, 2018 as compared to approximately $473,000 for the three months ended September 30, 2017. During the three months ended September 30, 2018, in addition to ongoing efforts at two major research universities, we also increased our research and development efforts at our Yonkers lab facility. These initiatives resulted in research and development expenses of $79,000 and stock-based compensation income of $28,000 during the three months ended September 30, 2018.

 

Net loss attributable to non-controlling interest was $0 for the three months ended September 30, 2018 as compared to net loss attributable to non-controlling interest of approximately $125,000 for the three months ended September 30, 2017, with such change resulting from our purchase of all of the outstanding shares of our former subsidiary, CLC. See Note 1 to the financial statements for more detail regarding CLC.

 

Nine Months Ended September 30, 2018 Compared to Nine Months Ended September 30, 2017

 

General and administrative expenses were approximately $3.4 million for the nine months ended September 30, 2018 as compared to approximately $3.2 million for the nine months ended September 30, 2017. The increase in general and administrative expenses mostly relates to an increase in payroll cost of $203,000 as compared to the prior period.

 

Legal and professional fees were approximately $364,000 for the nine months ended September 30, 2018 as compared to approximately $390,000 for the nine months ended September 30, 2017.

 

Research and development expenses amounted to $837,000 for the nine months ended September 30, 2018 as compared to approximately $1.1 million for the nine months ended September 30, 2017. The decrease in research and development expenses mostly relates to fair value change of non-employee stock-based compensation which resulted in income of $245,000 and expense of $783,000 for the nine months ended September 30, 2018 and 2017, respectively offset by additional contracts entered into with a national research lab and another major research university for additional work related to development and scale-up of our processes. The Company also commenced research and development efforts at the Company’s Yonkers lab facility, which is now fully operational. The lab has added scientific staff and equipment to analyze lithium and lithium anodes produced through our proprietary processes. This testing allows the Company to further refine its processes, to demonstrate the properties of its lithium in potential battery configurations and to develop data for use with potential commercial partners.

 

Net loss attributable to non-controlling interest was approximately $155,000 for the nine months ended September 30, 2018 as compared to net loss attributable to non-controlling interest of approximately $250,000 for the nine months ended September 30, 2017.

 

Going Concern

 

The Company’s condensed financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

 

As reflected in the condensed financial statements, the Company had an accumulated deficit of approximately $24.7 million at September 30, 2018, a net loss of approximately $4.6 million and approximately $3.0 million net cash used in operating activities for the nine months ended September 30, 2018. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company is attempting to further develop the intellectual property associated with its technology; broaden its patent portfolio; scale up production of various products; and begin generating revenue; however, the Company’s cash position is not sufficient to support its daily operations. The ability of the Company to continue as a going concern is dependent upon its ability to raise additional funds by way of a public or private offering and its ability to further develop its technology and generate sufficient revenue. While the Company believes in the viability of its technology and in its ability to raise additional funds by way of a public or private offering, there can be no assurances to that effect.

 

The condensed financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

 

 16 
 

 

Liquidity and Capital Resources

 

Restricted cash and long-term deposits at September 30, 2018 includes $50,000 of cash deposited with Chase Bank (“Chase”) as collateral for an irrevocable standby letter of credit associated our Yonkers office lease.

 

As of September 30, 2018, we had an accumulated deficit of approximately $24.7 million and working capital of approximately $417,000.

 

On February 8, 2018, we entered into a preferred stock purchase agreement (“Stock Purchase Agreement”) with several accredited and institutional investors, pursuant to which we agreed to issue and sell in a private placement 1,950 shares of Series A Preferred Stock, as well as 975,000 warrants to purchase the Company’s common stock, at a purchase price of $1,000 per share, for total gross proceeds of $1.95 million (including previous advances from related parties). The warrants have a 5-year term and an exercise price of $2.00.

 

On March 21, 2018, the Company entered into a private placement offering with an investor and issued 826,446 shares of its common stock for $1.0 million. In connection with this private placement, the Company issued 41,322 shares of common stock to a third party as a finder’s fee.

 

On August 23, 2018, the Company entered into a private placement offering with three investors and issued 666,665 shares of its common stock for $800,000.

 

We have limited funds to continue our operating activities. Future operating activities are expected to be funded by loans and investments from officers, directors and stockholders, until we begin to generate cash flows from operations.

 

The table below sets forth selected cash flow data for the periods presented (dollars in thousands):

 

  

Nine Months Ended September 30,

 
   2018   2017 
Net cash used in operating activities  $(3,018)  $(1,610)
Net cash (used in) provided by investing activities   (180)   75
Net cash provided by financing activities   3,700    1,778 
Net increase in cash and cash equivalents  $502   $243 

 

The success of our business plan during the next 12 months and beyond is contingent upon us generating sufficient revenue to cover our costs of operations, or upon us obtaining additional financing. We believe that our current capital resources are not sufficient to support our operations for the next 12 months. We intend to finance our operations through debt and/or equity financings. There can be no assurance that such additional financing will be available to us on acceptable terms, or at all. We intend to use all commercially-reasonable efforts at our disposal to raise sufficient capital to run our operations on a go forward basis.

 

Off Balance Sheet Arrangements

 

As of the date of this report, we have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to our stockholders.

 

Commitments

 

On March 22, 2016, we entered into a lease (the “Lease”) with Hudson View Building #3, LLC (“the “Landlord”), for office and laboratory space located in Yonkers, New York (the “Leased Premise”). The Leased Premise consists of approximately 8,000 square feet. The Lease has a term of 87 months from the lease commencement date, which is the date upon which the Landlord has substantially completed certain interior leasehold improvements to the Leased Premise. The annual rent of the first year of the lease is approximately $208,000, increasing by 1.5% on each anniversary of the lease commencement date. In the event of a termination of the lease following a default by the Company, the Company will be obligated to pay the sum of the rent payable for the remainder of the lease term. The Company moved into the office on May 30, 2017. The Company began paying the monthly rent during the quarter ended September 30, 2017. On March 31, 2018, we entered into a lease amendment agreement with the Landlord. Which resulted in abatement of rent for the period from October 2017 through March 2018, and the expiration date of the Lease was extended to March 31, 2025.

 

In connection with this lease, we obtained an Irrevocable Standby Letter of Credit (the “Letter of Credit”) from Chase Bank for a sum not exceeding $150,000. The Company has deposited this amount with Chase Bank as collateral for the Letter of Credit and recorded the amount as restricted cash and long-term deposits in the balance sheets. During the year ended December 31, 2017, $100,000 restricted cash was released to the Company.

 

 17 
 

 

As of September 30, 2018, contractual minimal lease payments are as follows (in thousands):

 

2018   $ 53  
2019     212  
2020     215  
2021     219  
2022     222  
Thereafter     511  
Total   $ 1,432  

 

Item 3. Quantitative and Qualitative Disclosures About Market Risk

 

Not applicable

 

Item 4. Controls and Procedures

 

Evaluation of Disclosure Controls and Procedures

 

We carried out an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) as of September 30, 2018. This evaluation was carried out under the supervision and with the participation of our Principal Executive Officer, and our Principal Financial and Accounting Officer. Based upon that evaluation, our Chief Executive Officer and Principal Financial and Accounting Officer concluded that, as of September 30, 2018, our disclosure controls and procedures were ineffective as of the end of the period covered, due to the following material weaknesses which are indicative of many small companies with limited staff: (i) inadequate segregation of duties and effective risk assessment; and (ii) insufficient written policies and procedures for accounting and financial reporting with respect to the requirements and application of both United States generally accepted accounting principles and Securities and Exchange Commission guidelines. Management anticipates that such disclosure controls and procedures will not be effective until the material weaknesses are remediated.

 

Disclosure controls and procedures are controls and other procedures that are designed to ensure that information required to be disclosed in our reports filed or submitted under the Exchange Act are recorded, processed, summarized and reported, within the time periods specified in the SEC’s rules and forms. Disclosure controls and procedures include, without limitation, controls and procedures designed to ensure that information required to be disclosed in our reports filed under the Exchange Act is accumulated and communicated to management, including our Principal Executive Officer, and Principal Financial and Accounting Officer, to allow timely decisions regarding required disclosure.

 

During 2018, we, together with our independent registered public accounting firm, identified material weaknesses in our internal control over financial reporting, as described below. A “material weakness” is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company’s annual or interim financial statements will not be prevented or detected on a timely basis. The material weaknesses in internal control over financial reporting resulted from operating deficiencies which are listed below. To remediate the material weaknesses, we are initiating controls and procedures to formally monitor new transactions and events that change our business so that we consider material impacts to our financial statements, including proper recording and disclosure of those transactions or events as well as documenting the related significant estimates and judgments made by management.

 

There are insufficient written policies and procedures to ensure the correct application of accounting and financial reporting with respect to the current requirements of GAAP and SEC disclosure requirements;
   
Insufficient segregation of duties, oversight of work performed and lack of compensating controls in the Company’s finance and accounting functions due to limited personnel;
   
Inadequate controls surrounding related party transactions, to ensure that all material transactions and developments impacting the financial statements are reflected and properly recorded;
   
Management has not performed a proper evaluation of 1) the disclosure controls and procedures and 2) internal control over financial reporting; and
   
Inadequate controls over Company arrangements and contract management.

 

 18 
 

 

Changes in Internal Control over Financial Reporting

 

There was no change in our internal control over financial reporting during the nine months ended September 30, 2018 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

 

PART II - OTHER INFORMATION

 

Item 1. Legal Proceedings

 

We are not currently involved in any litigation that we believe could have a material adverse effect on our financial condition and results of operations or cash flows.

 

Item 1A. Risk Factors.

 

There are no material changes to the risk factors in our most recent Annual Report on Form 10-K.

 

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

 

On August 23, 2018, the Company entered into a private placement offering with three accredited investors and issued 666,665 shares of its common stock for total aggregate consideration of $800,000. The securities sold in this offering were not registered under the Securities Act of 1933, as amended, or the securities laws of any state, and were offered and sold in reliance on the exemption from registration under the Securities Act of 1933, as amended, provided by Section 4(2) and Regulation D (Rule 506) under the Securities Act of 1933, as amended.

 

Item 3. Defaults upon Senior Securities.

 

None.

 

Item 4. Mine Safety Disclosures.

 

Not applicable.

 

Item 5. Other Information.

 

Not applicable.

 

Item 6. Exhibits

 

Exhibit Number   Description of Exhibit
31.1   Certification of Principal Executive Officer and Principal Financial and Accounting Officer, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
32.1   Certification of Principal Executive Officer and Principal Financial and Accounting Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS   XBRL Instance Document
101.SCH   XBRL Schema Document
101.CAL   XBRL Calculation Linkbase Document
101.DEF   XBRL Definition Linkbase Document
101.LAB   XBRL Label Linkbase Document
101.PRE   XBRL Presentation Linkbase Document

  

 19 
 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

 

alpha-En Corporation  
     
Date: November 14, 2018  
     
By: /s/ Jerome I. Feldman  
  Jerome I. Feldman  
  Executive Chairman and Treasurer  
     
Date: November 14, 2018  
     
By: /s/ Sam Pitroda  
  Sam Pitroda  
 

Chief Executive Officer

(principal executive officer)

 
     
Date: November 14, 2018  
     
By: /s/ Nathan J. Wasserman  
  Nathan J. Wasserman  
 

Chief Financial Officer

(principal financial and accounting officer)

 

 

 20 
 

 

 

EX-31.1 2 ex31-1.htm

 

EXHIBIT 31.1

 

CERTIFICATION PURSUANT TO

RULE 13a-14(a) OR RULE 15d-14(a) OF THE

SECURITIES EXCHANGE ACT OF 1934

 

The undersigned hereby certify that:

 

1. I have reviewed this Quarterly Report on Form 10-Q of alpha-En Corporation;
   
2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
   
3. Based on my knowledge, the financial statements, and other financial information included in this interim report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
   
4. The registrants’ other certifying officers and I am responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal controls over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

  a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant is made known to us by others, particularly during the period in which this report is being prepared;
     
  b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under my supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
     
  c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
     
  d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5. The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

  a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
     
  b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Date: November 14, 2018 /s/ Jerome I. Feldman
  Jerome I. Feldman
  Executive Chairman and Treasurer
   
Date: November 14, 2018 /s/ Sam Pitroda
  Sam Pitroda
  Chief Executed Officer
  (principal executive officer)
   
Date: November 14, 2018 /s/ Nathan J. Wasserman
  Nathan J. Wasserman
  Chief Financial Officer
  (principal financial and accounting officer)

 

   

 

 

EX-32.1 3 ex32-1.htm

 

EXHIBIT 32.1

 

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL FINANCIAL OFFICER

PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 906 OF THE

SARBANES-OXLEY ACT OF 2002

 

Pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, each of the undersigned officers of alpha-En Corporation (the “Company”), hereby certify, that, to his knowledge:

 

1. The Quarterly Report on Form 10-Q for the quarter ended September 30, 2018 (the “Report”) of the Company fully complies with the requirements of Section 13(a) or Section 15(d) of the Securities Exchange Act of 1934; and

 

2. The information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

Dated: November 14, 2018 /s/ Jerome I. Feldman
  Jerome I. Feldman
  Executive Chairman and Treasurer
   
Date: November 14, 2018 /s/ Sam Pitroda
  Sam Pitroda
  Chief Executive Officer
  (principal executive officer)
   
Date: November 14, 2018 /s/ Nathan J. Wasserman
  Nathan J. Wasserman
  Chief Financial Officer
  (principal financial and accounting officer)

 

   
 

 

EX-101.INS 4 alpe-20180930.xml XBRL INSTANCE FILE 0001023298 2018-01-01 2018-09-30 0001023298 2018-09-30 0001023298 us-gaap:CommonClassBMember 2018-09-30 0001023298 us-gaap:CommonClassBMember 2017-12-31 0001023298 2017-12-31 0001023298 ALPE:LabEquipmentMember 2017-12-31 0001023298 us-gaap:WarrantMember 2017-01-01 2017-09-30 0001023298 us-gaap:WarrantMember 2018-01-01 2018-09-30 0001023298 us-gaap:StockOptionMember 2018-01-01 2018-09-30 0001023298 us-gaap:StockOptionMember 2017-01-01 2017-09-30 0001023298 ALPE:LabEquipmentMember 2018-01-01 2018-09-30 0001023298 ALPE:OfficeFurnitureEquipmentMember 2018-01-01 2018-09-30 0001023298 ALPE:LabEquipmentMember 2018-09-30 0001023298 ALPE:OfficeFurnitureEquipmentMember 2018-09-30 0001023298 ALPE:LeaseholdImprovementMember 2018-09-30 0001023298 ALPE:OfficeFurnitureEquipmentMember 2017-12-31 0001023298 ALPE:LeaseholdImprovementMember 2017-12-31 0001023298 ALPE:EmployeeStockOptionAwardsMember 2018-01-01 2018-09-30 0001023298 ALPE:NonEmployeeStockOptionAwardsMember 2018-01-01 2018-09-30 0001023298 ALPE:NonEmployeeStockOptionAwardsMember 2017-01-01 2017-09-30 0001023298 ALPE:EmployeeStockOptionAwardsMember 2017-01-01 2017-09-30 0001023298 ALPE:BoardOfDirectorsMember 2017-03-29 0001023298 us-gaap:CommonClassBMember 2017-03-29 0001023298 ALPE:JeromeIFeldmanMember 2018-01-01 2018-09-30 0001023298 us-gaap:WarrantMember 2017-12-31 0001023298 ALPE:LeaseholdImprovementMember 2018-01-01 2018-09-30 0001023298 us-gaap:SeriesAPreferredStockMember 2017-12-31 0001023298 us-gaap:SeriesAPreferredStockMember 2018-01-01 2018-09-30 0001023298 us-gaap:SeriesAPreferredStockMember 2018-02-08 0001023298 us-gaap:SeriesAPreferredStockMember 2018-02-07 2018-02-08 0001023298 ALPE:EmployeeStockOptionAwardsMember 2017-12-31 0001023298 ALPE:NonEmployeeStockOptionAwardsMember 2017-12-31 0001023298 2017-09-30 0001023298 ALPE:CleanLithiumCorporationMember 2014-09-30 0001023298 ALPE:SeriesAPreferredMember srt:MinimumMember 2018-02-08 0001023298 ALPE:SeriesAPreferredMember srt:MaximumMember 2018-02-08 0001023298 ALPE:PreferredStockConvertibleIntoCommonStockMember 2017-01-01 2017-09-30 0001023298 ALPE:PreferredStockConvertibleIntoCommonStockMember 2018-01-01 2018-09-30 0001023298 ALPE:StevenMFludderMember 2018-01-01 2018-09-30 0001023298 ALPE:StevenMPayneMember 2018-02-07 2018-02-08 0001023298 ALPE:JeromeIFeldmanMember 2018-02-07 2018-02-08 0001023298 ALPE:JimKilmanMember ALPE:KielStrandCapitalLLCMember 2018-02-07 2018-02-08 0001023298 2017-01-01 2017-09-30 0001023298 2016-12-31 0001023298 us-gaap:ResearchAndDevelopmentExpenseMember 2018-01-01 2018-09-30 0001023298 us-gaap:ResearchAndDevelopmentExpenseMember 2017-01-01 2017-09-30 0001023298 srt:MinimumMember 2018-01-01 2018-09-30 0001023298 srt:MaximumMember 2018-01-01 2018-09-30 0001023298 us-gaap:PreferredStockMember 2018-01-01 2018-09-30 0001023298 ALPE:PitrodaGroupLLCMember 2018-02-08 0001023298 ALPE:OtherAccreditedAndInstitutionalInvestorsMember 2018-02-08 0001023298 us-gaap:SeriesAPreferredStockMember 2018-09-30 0001023298 ALPE:EmployeeStockOptionAwardsMember 2018-09-30 0001023298 ALPE:NonEmployeeStockOptionAwardsMember 2018-09-30 0001023298 us-gaap:WarrantMember 2018-01-01 2018-09-30 0001023298 us-gaap:WarrantMember 2018-09-30 0001023298 us-gaap:CommonStockMember 2018-01-01 2018-09-30 0001023298 us-gaap:CommonStockMember 2017-12-31 0001023298 us-gaap:CommonStockMember 2018-09-30 0001023298 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-09-30 0001023298 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0001023298 us-gaap:AdditionalPaidInCapitalMember 2018-09-30 0001023298 us-gaap:TreasuryStockMember 2018-01-01 2018-09-30 0001023298 us-gaap:TreasuryStockMember 2017-12-31 0001023298 us-gaap:TreasuryStockMember 2018-09-30 0001023298 us-gaap:RetainedEarningsMember 2018-01-01 2018-09-30 0001023298 us-gaap:RetainedEarningsMember 2017-12-31 0001023298 us-gaap:RetainedEarningsMember 2018-09-30 0001023298 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-09-30 0001023298 us-gaap:NoncontrollingInterestMember 2017-12-31 0001023298 us-gaap:NoncontrollingInterestMember 2018-09-30 0001023298 2018-07-01 2018-09-30 0001023298 2017-07-01 2017-09-30 0001023298 us-gaap:ResearchAndDevelopmentExpenseMember 2018-07-01 2018-09-30 0001023298 us-gaap:ResearchAndDevelopmentExpenseMember 2017-07-01 2017-09-30 0001023298 ALPE:CleanLithiumCorporationMember 2016-12-31 0001023298 ALPE:CleanLithiumCorporationMember 2015-01-01 2016-12-31 0001023298 ALPE:CleanLithiumCorporationMember 2018-06-02 2018-06-14 0001023298 ALPE:MrPitrodaMember 2018-05-01 2018-05-31 0001023298 us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedDividendRateMember 2018-09-30 0001023298 us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2018-09-30 0001023298 us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputOptionVolatilityMember 2018-09-30 0001023298 us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedTermMember 2018-01-01 2018-09-30 0001023298 ALPE:StevenFludderMember 2017-08-31 2017-09-01 0001023298 us-gaap:StockOptionMember 2018-07-01 2018-09-30 0001023298 us-gaap:ShareBasedCompensationAwardTrancheOneMember 2018-01-01 2018-09-30 0001023298 us-gaap:ShareBasedCompensationAwardTrancheTwoMember 2018-01-01 2018-09-30 0001023298 us-gaap:ShareBasedCompensationAwardTrancheThreeMember 2018-01-01 2018-09-30 0001023298 us-gaap:SeriesAPreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedTermMember 2018-02-07 2018-02-08 0001023298 us-gaap:SeriesAPreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputOptionVolatilityMember 2018-02-08 0001023298 us-gaap:SeriesAPreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputRiskFreeInterestRateMember 2018-02-08 0001023298 us-gaap:SeriesAPreferredStockMember us-gaap:ValuationTechniqueOptionPricingModelMember us-gaap:MeasurementInputExpectedDividendRateMember 2018-02-08 0001023298 us-gaap:InvestorMember 2018-01-01 2018-09-30 0001023298 ALPE:EmployeeStockOptionAwardsMember 2018-07-01 2018-09-30 0001023298 ALPE:NonEmployeeStockOptionAwardsMember 2018-07-01 2018-09-30 0001023298 ALPE:EmployeeStockOptionAwardsMember 2017-07-01 2017-09-30 0001023298 ALPE:NonEmployeeStockOptionAwardsMember 2017-07-01 2017-09-30 0001023298 us-gaap:StockOptionMember 2018-01-01 2018-09-30 0001023298 ALPE:StockOptionOneMember 2018-07-01 2018-09-30 0001023298 2018-06-14 0001023298 us-gaap:PrivatePlacementMember 2018-01-01 2018-09-30 0001023298 ALPE:UnvestedEmployeeStockOptionsMember 2018-01-01 2018-09-30 0001023298 ALPE:StockOptionsMember 2017-01-01 2017-09-30 0001023298 ALPE:StockOptionsMember 2018-01-01 2018-09-30 0001023298 2018-11-13 0001023298 us-gaap:PrivatePlacementMember 2018-08-21 2018-08-23 0001023298 ALPE:MrPitrodaMember ALPE:EmploymentAgreementMember 2018-01-01 2018-09-30 0001023298 ALPE:SeriesAPreferredStockOneMember 2018-01-01 2018-09-30 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure alpha-En Corp 10-Q 2018-09-30 false --12-31 ALPE 390000 334000 21301000 18482000 -3097000 -2233000 334000 390000 18482000 21301000 -69000 -69000 -20276000 -24719000 -704000 0.01 0.01 0.01 0.01 57000000 1000000 1000000 57000000 57000000 1000000 39044589 33350506 38329839 32635756 714750 714750 -4598000 -4752000 -4443000 -155000 -1689000 -2440000 -0.18 -0.18 -0.05 -0.07 35693698 33300837 35890676 33337722 33350506 39044589 714750 714750 <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of options granted during the nine months ended September 30, 2018 and 2017 were estimated using the following weighted-average assumptions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Nine Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font-size: 10pt">Exercise price</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2.05</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">1.85</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Expected stock price volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">78</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">79</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Risk-free rate of interest</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2.68</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1.61</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Term (years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.0</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.1</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of option activity under the Company&#8217;s employee stock option plan for the nine months ended September 30, 2018 is presented below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br /> <font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total Intrinsic Value</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life (in years)</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">Outstanding as of December 31, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">5,669,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">1.48</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">7,793,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">4.3</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 10pt"><font style="font-size: 10pt">Employee options granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,610,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2.06</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">19,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6.5</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 10pt"><font style="font-size: 10pt">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(100,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.20</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">152,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-indent: 10pt"><font style="font-size: 10pt">Expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(250,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.10</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">443,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Outstanding as of September 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">12,929,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1.85</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,649,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5.4</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Options vested and expected to vest as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">12,929,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.85</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,649,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5.4</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Options vested and exercisable as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,336,500</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.51</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,185,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.9</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of activity of options granted to non-employees for the nine months ended September 30, 2018 is presented below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br /> <font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total Intrinsic Value</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life (in years)</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">Outstanding as of December 31, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">3,205,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">0.40</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">7,847,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2.4</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 10pt"><font style="font-size: 10pt">Non-employee options granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1.64</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">22,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.0</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 10pt"><font style="font-size: 10pt">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(10,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.20</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">22,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-indent: 10pt"><font style="font-size: 10pt">Expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(300,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.15</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">491,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Outstanding as of September 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,095,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.51</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,767,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2.0</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Options vested and expected to vest as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,095,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.51</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">3,767,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2.0</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Options vested and exercisable as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,582,500</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.47</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">3,223,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1.9</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the status of the Company&#8217;s outstanding warrants as of September 30, 2018 and changes during the nine months then ended is presented below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Warrants</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br /> <font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total Intrinsic Value</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life (in years)</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">Outstanding as of December 31, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">4,744,292</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">1.24</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">7,884,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">3.6</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Issued</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">975,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2.00</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.4</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-indent: 9pt"><font style="font-size: 10pt">Exercised</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,000,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.20</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,680,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Outstanding as of September 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,719,292</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1.62</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,830,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.3</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Warrants exercisable as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4,469,292</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.64</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,705,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.2</font></td> <td>&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation expense for the nine months ended September 30, 2018 and 2017 was comprised of the following (dollars in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Three Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Nine Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">Employee stock option awards</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">862</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">1,367</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">2,250</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">1,723</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Non-employee option awards</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(22</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">273</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(318</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">983</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total compensation expense</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">840</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,640</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,932</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,706</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> -4443000 -4502000 -1689000 -2315000 3396000 3188000 1213000 1751000 364000 390000 103000 135000 837000 1093000 372000 473000 4597000 4671000 1688000 2359000 -155000 -250000 -125000 0001023298 Non-accelerated Filer 39044589 1779000 1113000 -704000 -3097000 -1529000 -24719000 -20276000 69000 69000 687000 771000 1411000 662000 1411000 617000 1103000 1779000 1113000 665000 501000 1079000 577000 15000 15000 35000 35000 1064000 562000 502000 243000 22000 15000 7000 42000 150000 22000 180000 25000 -553000 62000 -2000 1932000 2706000 83000 41000 32000 24000 2018 Q3 249000 0.01 0.01 5000000 5000000 4105 1935 4105 1935 275000 68000 100000 46000 687000 649000 956000 807000 -6361000 -6026000 -1789000 -2361000 956000 807000 250000 150000 0.75 60000000 2000000 2000 5000 0.01 0.0905 1.00 P3Y P3Y P7Y P3Y P7Y 23091352 4744292 4719292 16024000 8880000 2348060 13624292 825000 578000 173000 415000 31000 379000 31000 374000 100000 50000 100000 250000 975000 250000 1950000 P5Y 2.00 956000 1935000 4105000 1935 4105 250000 250 -956000 956000 687000 -687000 2.05 1.48 0.40 1.85 1.85 0.51 7610000 200000 7000000 2.06 1.64 2.08 4744292 4719292 975000 4469292 1.24 1.62 1.64 P3Y3M19D 1932000 2250000 -318000 983000 1723000 2706000 -245000 783000 840000 1640000 -28000 243000 466000 862000 -22000 1367000 273000 622000 210000 7629000 4105000 1935000 4105000 1935000 1950 905000 3018190 -275000 275000 -275000 1000 100000 10000 110000 385000 0.78 0.79 0.0268 0.0161 P4Y P3Y1M6D P3Y7M6D P4Y4M24D P3Y2M12D 5669000 3205000 12929000 3095000 7793000 7847000 1649000 3767000 19000 22000 P4Y3M19D P2Y4M24D P6Y6M0D P4Y0M0D P5Y4M24D P2Y0M0D P5Y4M24D P2Y0M0D P3Y10M25D P1Y10M25D 687000 649000 36000 308000 500000 500 1700 1700000 250000 300000 0.10 0.15 12929000 3095000 3336500 2582500 1.85 0.51 1.51 0.47 1649000 3767000 1185000 3223000 443000 491000 P0Y P0Y P0Y P0Y 152000 22000 Due to the reduction of allocated proceeds to Series A Preferred, the effective conversion price was approximately $1.13 per share 1200000 3700000 1778000 -3018000 -1610000 -180000 75000 275 0.10 1932000 1932000 22000 1000 21000 687000 687000 687000 687000 956000 956000 -956000 -956000 3018190 30000 -889000 859000 1534433 41322 826446 666665 1800000 15000 1785000 1000000 800000 -55 572 31460 31460 55000 -55000 55000 1000000 200000 10000 190000 200000 1700000 1670000 1800000 55000 104000 100000 7600000 0.00 0.027 0.780 0.748 0.0257 0.00 P4Y P5Y P4Y1M2D 150000 3.00 6.00 11.00 2000000 4000000 7000000 0.285 0.517 1.000 4600000 8400000 -1000000 0.20 P0Y 1064000 562000 685000 442000 9000 109000 118000 P7Y <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b>Note 1 - Organization and Operations</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">alpha-En Corporation (the &#8220;Company&#8221;) was incorporated in Delaware on March 7, 1997.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Since 2008, the focus of the Company&#8217;s business has been developing new technologies for manufacturing highly pure lithium metal, a raw material for use in lightweight, high energy density batteries, in an environmentally friendly manner for commercial purposes. In 2013, the Company invented a new process for the production of highly pure lithium metal and associated products at room temperature. The Company subsequently broadened its focus to develop products and processes derived from the Company&#8217;s new core proprietary technology, including battery components and compounds of lithium.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Ownership of Subsidiary</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In September 2014, alpha-En Corporation formed Clean Lithium Corporation (&#8220;CLC&#8221;) under the laws of New York State as a wholly owned subsidiary with a nominal share capital of $100,000. From 2014 to 2016, the Company sold 9.05% or 905,000 of CLC&#8217;s shares to minority equity holders. Effective as of June 14, 2018, the Company completed the purchase all of the outstanding shares of CLC such that CLC became a wholly-owned subsidiary of the Company and was immediately thereafter merged with and into the Company, with the Company surviving. In connection with this transaction, the former minority equity holders of CLC prior to the merger received an aggregate total of 3,018,190 shares of common stock of the Company. The Company recorded the acquisition of CLC as a capital transaction.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b><i>Amended and Restated Certificate of Incorporation</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 29, 2017 the Board of Directors of the Company and a subset of the Company&#8217;s stockholders representing in excess of 75% of the Company&#8217;s currently issued and outstanding voting stock approved of the amendment and restatement of the Company&#8217;s Certificate of Incorporation (the &#8220;Restated Certificate&#8221;) to make certain corporate governance updates and to increase the authorized capital stock of the Company to 60,000,000 shares, of which 57,000,000 are shares of Common Stock, par value $0.01 per share, 1,000,000 are shares of Class B Common Stock, par value $0.01 per share and 2,000,000 are shares of preferred stock, par value $0.01 per share. The Company filed a definitive information statement on Schedule 14C with the Securities and Exchange Commission on June 1, 2017 describing the changes in the Restated Certificate. The Restated Certificate was filed with the Secretary of State for the State of Delaware and became effective on June 30, 2017. On February 8, 2018 the Company filed with the Secretary of State of the State of Delaware an amended and restated certificate of incorporation increasing the authorized number of preferred shares designated as series A preferred from 2,000 to 5,000.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 2 - Going Concern and Liquidity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s condensed financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As reflected in the condensed financial statements, the Company had an accumulated deficit of approximately $24.7 million at September 30, 2018, a net loss of approximately $4.6 million and approximately $3.0 million net cash used in operating activities for the nine months ended September 30, 2018. These factors raise substantial doubt about the Company&#8217;s ability to continue as a going concern.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company is attempting to further develop the intellectual property associated with its technology; broaden its patent portfolio; scale up its production of various products; and begin generating revenue; however, the Company&#8217;s cash position is not sufficient to support its daily operations for the foreseeable future. The ability of the Company to continue as a going concern is dependent upon its ability to raise additional funds by way of a public or private offering and its ability to further develop its technology and generate sufficient revenue. While the Company believes in the viability of its technology and in its ability to raise additional funds by way of a public or private offering, there can be no assurances to that effect.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The condensed financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 3 - Significant and Critical Accounting Policies and Practices</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis of Presentation and Principles of Consolidation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 14, 2018 the Company completed the purchase all of the outstanding shares of CLC such that CLC became a wholly-owned subsidiary of the Company and was immediately thereafter merged with and into the Company, with the Company surviving. Accordingly, as of June 14, 2018 the Company no longer has any subsidiaries consolidated in these financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended December 31, 2017 and through June 14, 2018, the accompanying condensed consolidated financial statements include the accounts of the Company&#8217;s subsidiaries. For consolidated entities where the Company owns less than 100% of the subsidiary, the Company records net loss attributable to non-controlling interests in its condensed consolidated statements of operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The condensed consolidated balance at December 31, 2017 was derived from audited annual financial statements but do not contain all of the footnote disclosures from the annual financial statements. The unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and reflect all adjustments (consisting of normal recurring adjustments unless otherwise indicated) which, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain information in footnote disclosures normally included in the financial statements prepared in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the SEC rules and regulations for interim reporting. The financial results for the periods presented may not be indicative of the full year&#8217;s results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These unaudited condensed financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2017 included in the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s condensed financial statements include certain amounts that are based on management&#8217;s best estimates and judgments. The Company&#8217;s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, fair value used in estimating the value of warrants, stock-based compensation, accrued expenses and provisions for income taxes. Due to the uncertainty inherent in such estimates, actual results may differ from these estimates.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cash</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2018 and December 31, 2017, substantially all of the Company&#8217;s cash was held by major financial institutions and the balance at certain times may exceed the maximum amount insured by the Federal Deposits Insurance Corporation. However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Property and Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lab equipment, leasehold improvements and office equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of each asset, generally three to seven years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.9pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Impairment of Long-Lived Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. There were no indicators of impairment for long-lived assets during the nine months ended September 30, 2018.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Fair Value of Preferred Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.7pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of Preferred stock was estimated based upon equivalent common shares that Preferred Stock could have been converted into at the closing price on the purchase date.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Financial Instruments</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company bifurcates conversion options from their host instruments and accounts for them as free standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument. Deemed dividends are also recorded for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Research and Development</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. Upfront and milestone payments due to third parties that perform research and development services on the Company&#8217;s behalf will be expensed as services are rendered or when the milestone is achieved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17.6pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs primarily consist of personnel related expenses, including salaries, benefits, travel, and other related expenses, stock-based compensation, payments made to third parties for license and milestone costs related to in-licensed products and technology, payments made to third party contract research organizations, consultants, the cost of acquiring and manufacturing research trial materials, and costs associated with regulatory filings, laboratory costs and other supplies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.9pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 730-10-25-1, <i>Research and Development</i>, costs incurred in obtaining technology licenses are charged to research and development expense if the technology licensed has not reached commercial feasibility and has no alternative future use. Certain licenses purchased by the Company require substantial completion of research and development and regulatory and marketing approval efforts in order to reach commercial feasibility and have no alternative future use.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30, 2018, in addition to ongoing efforts at one major research university, the Company entered into additional contracts with a national research lab and another major research university for additional work related to development and scale-up of the Company&#8217;s processes. The Company also commenced research and development efforts at the Company&#8217;s Yonkers lab facility.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accruals for contingencies and legal proceedings expected to be incurred in connection with a loss contingency when it is probable that a liability has been incurred and the amount can be reasonably estimated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If a loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock-Based Compensation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses stock-based compensation to employees over the requisite service period based on the estimated grant-date fair value of the awards. For stock-based compensation awards to non-employees, the Company remeasures the fair value of the non-employee awards at each reporting period prior to vesting and finally at the vesting date of the award. Changes in the estimated fair value of these non-employee awards are recognized as compensation expense in the period of change.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates the fair value of stock options grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management&#8217;s best estimates and involve inherent uncertainties and the application of management&#8217;s judgment.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Loss Per Share</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share excludes the potential impact of common stock options, convertible preferred stock and outstanding common stock purchase warrants because their effect would be anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Warrants to purchase common stock</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,719,292</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,744,292</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Options to purchase common stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">16,024,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">8,880,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Preferred stock convertible into common stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,348,060</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt"><b>Total</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>23,091,352</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>13,624,292</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Non-Controlling Interests</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third parties. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recent Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers the applicability and impact of all Accounting Standard Updates (&#8220;ASUs&#8221;). ASUs not discussed below were assessed and determined to be either not applicable or are expected to have minimal impact on our balance sheets or statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2018-13, &#8220;Fair Value Measurement (Topic 820), &#8211; Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement,&#8221; which makes a number of changes meant to add, modify or remove certain disclosure requirements associated with the movement amongst or hierarchy associated with Level 1, Level 2 and Level 3 fair value measurements. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the update. The Company is still evaluating but does not expect the adoption of this guidance to have a material impact on its condensed Financial Statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders&#8217; equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders&#8217; equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company plans to adopt this change in Q1 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07, &#8220;Improvements to Nonemployee Share-Based Payment Accounting&#8221;, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The changes take effect for public companies for fiscal years starting after December 15, 2018, including interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity&#8217;s adoption date of Topic 606. We are still evaluating but expect the adoption of this pronouncement will eliminate significant fluctuation in stock based compensation expensed in the past due to awards to non-employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception, (ASU 2017-11). Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company is currently assessing the potential impact of adopting ASU 2017-11 on its financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2017, the FASB issued ASU 2017-09, <i>Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting</i>, (ASU 2017-09). ASU 2017-09 provides clarity and reduces both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, to a change to the terms or conditions of a share-based payment award. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company adopted this ASU on January 1, 2018 and the adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) and subsequent amendments to the initial guidance: ASU 2017-13, ASU 2018-10 and ASU 2018-11 (collectively, Topic 842). Topic 842 requires companies to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. Topic 842 is effective for us in our first quarter of fiscal 2020, and earlier adoption is permitted. We are currently evaluating the impact of our pending adoption of Topic 842 on our consolidated financial statements. We currently expect that most of our operating lease commitments (see MD&#38;A for commitments) will be subject to the new standard and recognized as operating lease liabilities and right-of-use assets upon our adoption of Topic 842, which will increase our total assets and total liabilities that we report relative to such amounts prior to adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases which clarifies, corrects or consolidates authoritative guidance issued in ASU 2016-02 and is effective upon adoption of ASU 2016-02. In July 2018, the FASB issued ASU 2018-11, Targeted Improvements, which provides an optional transition method that allows entities to elect to apply the standard prospectively at its effective date, versus recasting the prior periods presented. If elected, an entity would recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. The Company is still evaluating the method of adopting the standard.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company adopted the standard as of January 1, 2018 and adoption did not have a material impact on its condensed statement of cash flows.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 4 - Property and Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The components of property and equipment as of September 30, 2018 and December 31, 2017, at cost are (dollars in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Useful Life (Years)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 41%"><font style="font-size: 10pt">Lab equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">415</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">173</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Office furniture and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">31</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">31</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Leasehold improvement</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">7</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">379</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">374</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Gross property and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">825</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">578</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Accumulated depreciation and amortization</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(160</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(77</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Property and equipment, net</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">665</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">501</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s depreciation and amortization expense for the three and nine months ended September 30, 2018 was $32,000 and $83,000, and $24,000 and $41,000 for the three and nine months ended September 30, 2017, respectively.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 5 - Related Party Transactions</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Advances from Stockholders</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">From time to time, stockholders of the Company advances funds to the Company for working capital purposes. Those advances are unsecured, non-interest bearing and due on demand.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2018 and December 31, 2017, the outstanding amounts of the advances from related parties was approximately $36,000 and $308,000, respectively. During the nine months ended September 30, 2018, the Company repaid $15,000 in advances to Jerome Feldman and $7,000 to Steven Fludder and $250,000 was converted into preferred stock. See Note 6 for more details on advances converted to preferred stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><i><u>Employment Agreement with Chief Executive Officer</u></i></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On November 11, 2017, the Company appointed Sam Pitroda to serve as the Company&#8217;s new Chief Executive Officer. Since that time, Mr. Pitroda has served as CEO without an employment agreement. The Company and Mr. Pitroda are in discussions to finalize the terms of the employment agreement, although there can be no assurances that an agreement will be reached. On May 31, 2018, the board of directors approved to grant Mr. Pitroda an option to purchase 7,000,000 shares of the Company&#8217;s common stock at an exercise price of $2.08 per share. The option expires seven years from the option grant date. The stock subject to the option will vest upon the earlier to occur of (1) the five-year anniversary of the option grant date or (2) the achievement of certain stock price and volume milestones, which are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>For 20 consecutive business</b></font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Total option shares that</b></font></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Common stock price</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>days, with average daily</b></font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>become vested on satisfaction</b></font></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>closes at or above</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>volumn in excess of</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>of conditions</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; text-align: center"><font style="font-size: 10pt">$</font></td> <td style="width: 26%; text-align: right"><font style="font-size: 10pt">3.00</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 31%; text-align: center"><font style="font-size: 10pt">20,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 39%; text-align: center"><font style="font-size: 10pt">2,000,000 (28.5%)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">6.00</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">40,000</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">4,000,000 (51.7%)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">11.00</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">60,000</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">7,000,000 (100.0%)</font></td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The total fair value of this option award on the grant date was approximately $7.6 million. The fair value of the option award was determined using the Black-Scholes model with the following assumptions: risk free interest rate &#8211; 2.7%, volatility &#8211; 78.0%, expected term &#8211; 4 years and dividends&#8211; N/A. The Company will amortize the option over its service period of 4.09 years which was derived from a Monte Carlo simulation. Stock-based compensation expense for this option recognized for the three and nine months ended September 30, 2018 was $466,000 and $622,000, respectively.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On September 1 2017, Steven Fludder, former CEO, resigned from the Company. On June 22, 2018, the Company vested 150,000 stock options that would have been forfeited. The Company recorded additional stock compensation expense of $210,000 related to this stock option modification.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 6 - Temporary Equity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the Company&#8217;s Series A Preferred Stock activities for the nine months ended September 30, 2018 (dollars in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Series A Preferred Stock</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Amount</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 64%"><font style="font-size: 10pt">Total temporary equity as of December 31, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">1,935</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">1,935</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Sale of Series A preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,700</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,700</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Conversion of advances into preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">250</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">250</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Preferred stock converted to common stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(55</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(55</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Beneficial conversion feature of Series A preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(956</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Deemed dividends related to beneficial conversion feature of Series A preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">956</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Accrued Series A dividends</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">275</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">275</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Deemed dividend on Series A preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">687</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Fair Value of common stock warrant issued with Series A preferred stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(687</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total temporary equity as of September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4,105</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4,105</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On February 8, 2018, the Company entered into a preferred stock purchase agreement (&#8220;Stock Purchase Agreement&#8221;) with several accredited and institutional investors, pursuant to which the Company agreed to issue and sell in a private placement 1,950 shares of Series A Preferred Stock, as well as 975,000 warrants to purchase the Company&#8217;s common stock, at a purchase price of $1,000 per share, for total gross proceeds of $1.95 million (including previous advances from related parties). The warrants have a 5-year term and an exercise price of $2.00. Steven M. Payne converted $100,000, Jerome I. Feldman converted $50,000 and Jim Kilman through KielStrand Capital LLC converted $100,000&#160;advances into preferred stock. Sam Pitroda through Pitroda Group LLC invested $500,000 and the Company issued 500 Series A Preferred Stock and 250,000 warrants on the same terms as other accredited and institutional investors.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Series A Preferred is entitled to accrue cumulative dividends at a rate equal to 10.0% simple interest per annum on the original issue price of $1,000 per share (the &#8220;Original Issue Price&#8221;). Accrued dividends will be payable quarterly based on a 365-day year and may be paid in cash or in additional shares of Series A Preferred. Each share of Series A Preferred is convertible into 572 shares of Common Stock, subject to customary increases or decreases for stock splits, stock dividends recapitalizations and the like, and may be converted to Common Stock at any time after issuance at the option of a holder. The Company will have the right, at the Company&#8217;s option, to redeem all or a portion of the shares of Series A Preferred Stock at any time or times after the one year anniversary of the Issuance Date of such Series A Preferred Stock, at a price per share (the &#8220;Redemption Price&#8221;) equal to the sum of the following (without duplication): (a) the Original Issue Price, plus (b) any accrued but unpaid Dividends. Upon any liquidation, dissolution or winding up of the Company, liquidation of the Company&#8217;s assets will be made in the following order of priority: (a) first, payment or provision for payment of debts and other liabilities; (b) second, payment to the holders of Series A Preferred an amount with respect to each share of Series A Preferred equal to the Original Issue Price, plus any accrued but unpaid Dividends thereon; and (c) third, payment to the holders of Common Stock. Except as required by applicable law or as set forth herein, the holders of shares of Series A Preferred Stock will vote together with the holders of shares of Common Stock and not as a separate class. Each share of Series A Preferred Stock will have a number of votes equal to the number of shares of Common Stock then issuable upon conversion of such share of Series A Preferred Stock.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Series A Preferred Stock is being classified as temporary equity because it has redemption features that are outside of the Company&#8217;s control upon certain triggering events, such as a deemed liquidation event. A &#8220;Deemed Liquidation Event&#8221; is defined in the Company&#8217;s Amended and Restated Certificate of Incorporation as a merger that results in a change in control or the sale of substantially all the assets of the Company. In the case of a Deemed Liquidation Event, the assets of the Company will be paid in order of liquidation preference to the holders of preferred and common stock. Because certain holders of the Series A Preferred Stock constitute a majority of the Company&#8217;s Board of Directors, a potential Deemed Liquidation Event is considered to be outside the control of the Company along with the call provision that can be exercised in one year, resulting in classification of the Series A Preferred Stock as temporary equity.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company has determined that the warrants should be accounted as a component of stockholders&#8217; equity. On the issuance date, the Company estimated the fair value of the warrants at $1.2 million using the Black-Scholes option pricing model using the following primary assumptions: contractual term of 5.0 years, volatility rate of 74.8%, risk-free interest rate of 2.57% and expected dividend rate of 0%. Based on the warrant&#8217;s relative fair value to the fair value of the Series A Preferred, approximately $687,000 of the $1.2 million of aggregate fair value was allocated to the warrants, creating a corresponding preferred stock discount in the same amount.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Due to the reduction of allocated proceeds to Series A Preferred, the effective conversion price was approximately $1.13 per share creating a beneficial conversion feature of $956,000 which reduced the carrying value of the Series A Preferred. Since the conversion option of the Series A Preferred was immediately exercisable, the beneficial conversion feature was immediately accreted to preferred dividends, resulting in an increase in the carrying value of the Series A Preferred.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During nine months ended September 30, 2018, there were 55 shares of preferred stock converted into 31,460 shares of common stock. As of September 30, 2018, the dividends accrued and outstanding were $385,000 and reflected in carrying value of temporary equity.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Note 7 - Stockholders&#8217; (Deficit) Equity</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Common Stock</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On March 21, 2018, the Company entered into a private placement offering with an investor and issued 826,446 shares of its common stock for $1.0 million. In addition, the Company granted this investor the non-exclusive rights to distribute its product in China for a period of two years. In connection with this private placement, the Company issued 41,322 shares of common stock to an investor as a finder&#8217;s fee.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On August 23, 2018, the Company entered into a private placement offering with three investors and issued 666,665 shares of its common stock for $800,000.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>&#160;</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Stock Options</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of the Company&#8217;s common stock was based upon the publicly quoted price on the date that the final approval of the awards was obtained. The Company does not expect to pay dividends in the foreseeable future so therefore the expected dividend yield is 0%. The expected term for stock options granted with service conditions represents the average period the stock options are expected to remain outstanding and is based on the expected term calculated using the approach prescribed by the Securities and Exchange Commission&#8217;s Staff Accounting Bulletin for &#8220;plain vanilla&#8221; options. The expected term for stock options granted with performance and/or market conditions represents the period estimated by management by which the performance conditions will be met. The Company obtained the risk-free interest rate from publicly available data published by the Federal Reserve. The Company uses a methodology in estimating its volatility percentage from a computation that was based on a comparison of average volatility rates of similar companies to a computation based on the standard deviation of the Company&#8217;s own underlying stock price&#8217;s daily logarithmic returns. The grant date fair value of stock options granted during the nine months ended September 30, 2018 and 2017 was $8.4 million and $4.6 million, respectively. The fair value of options granted during the nine months ended September 30, 2018 and 2017 were estimated using the following weighted-average assumptions:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Nine Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 54%"><font style="font-size: 10pt">Exercise price</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">2.05</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 20%; text-align: right"><font style="font-size: 10pt">1.85</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Expected stock price volatility</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">78</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">79</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Risk-free rate of interest</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2.68</font></td> <td><font style="font-size: 10pt">%</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1.61</font></td> <td><font style="font-size: 10pt">%</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Term (years)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.0</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.1</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of option activity under the Company&#8217;s employee stock option plan for the nine months ended September 30, 2018 is presented below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br /> <font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total Intrinsic Value</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life (in years)</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">Outstanding as of December 31, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">5,669,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">1.48</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">7,793,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">4.3</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 10pt"><font style="font-size: 10pt">Employee options granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">7,610,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2.06</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">19,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">6.5</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 10pt"><font style="font-size: 10pt">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(100,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.20</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">152,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-indent: 10pt"><font style="font-size: 10pt">Expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(250,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.10</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">443,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Outstanding as of September 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">12,929,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1.85</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,649,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">5.4</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Options vested and expected to vest as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">12,929,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.85</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,649,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">5.4</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Options vested and exercisable as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,336,500</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.51</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,185,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.9</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Estimated future stock-based compensation expense relating to unvested employee stock options is approximately $8.3 million as of September 30, 2018 and will be amortized over 4.0 years.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of activity of options granted to non-employees for the nine months ended September 30, 2018 is presented below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br /> <font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total Intrinsic Value</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life (in years)</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">Outstanding as of December 31, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">3,205,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">0.40</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">7,847,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">2.4</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-indent: 10pt"><font style="font-size: 10pt">Non-employee options granted</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">200,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1.64</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">22,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.0</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-indent: 10pt"><font style="font-size: 10pt">Exercised</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(10,000</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">0.20</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">22,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt; text-indent: 10pt"><font style="font-size: 10pt">Expired</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(300,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.15</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">491,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Outstanding as of September 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,095,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.51</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3,767,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2.0</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Options vested and expected to vest as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3,095,000</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.51</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">3,767,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2.0</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Options vested and exercisable as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2,582,500</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">0.47</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">3,223,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1.9</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Warrants</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">A summary of the status of the Company&#8217;s outstanding warrants as of September 30, 2018 and changes during the nine months then ended is presented below:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Number of Warrants</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average</b></font><br /> <font style="font-size: 10pt"><b>Exercise Price</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Total Intrinsic Value</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Weighted Average Remaining Contractual Life (in years)</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">Outstanding as of December 31, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">4,744,292</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">1.24</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 8%; text-align: right"><font style="font-size: 10pt">7,884,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 14%; text-align: right"><font style="font-size: 10pt">3.6</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-left: 10pt"><font style="font-size: 10pt">Issued</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">975,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">2.00</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4.4</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt; text-indent: 9pt"><font style="font-size: 10pt">Exercised</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(1,000,000</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">0.20</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,680,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Outstanding as of September 30, 2018</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">4,719,292</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1.62</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">1,830,000</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">3.3</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Warrants exercisable as of September 30, 2018</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">4,469,292</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1.64</font></td> <td>&#160;</td> <td>&#160;</td> <td><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">1,705,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3.2</font></td> <td>&#160;</td></tr> </table> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0"><b><i>Stock-based Compensation Expense</i></b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Stock-based compensation expense for the nine months ended September 30, 2018 and 2017 was comprised of the following (dollars in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Three Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>For the Nine Months Ended September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 48%"><font style="font-size: 10pt">Employee stock option awards</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">862</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">1,367</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">2,250</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 10%; text-align: right"><font style="font-size: 10pt">1,723</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Non-employee option awards</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(22</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">273</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(318</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">983</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total compensation expense</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">840</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,640</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">1,932</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">2,706</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Basis of Presentation and Principles of Consolidation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">On June 14, 2018 the Company completed the purchase all of the outstanding shares of CLC such that CLC became a wholly-owned subsidiary of the Company and was immediately thereafter merged with and into the Company, with the Company surviving. Accordingly, as of June 14, 2018 the Company no longer has any subsidiaries consolidated in these financial statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">For the year ended December 31, 2017 and through June 14, 2018, the accompanying condensed consolidated financial statements include the accounts of the Company&#8217;s subsidiaries. For consolidated entities where the Company owns less than 100% of the subsidiary, the Company records net loss attributable to non-controlling interests in its condensed consolidated statements of operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The condensed consolidated balance at December 31, 2017 was derived from audited annual financial statements but do not contain all of the footnote disclosures from the annual financial statements. The unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the &#8220;SEC&#8221;) and reflect all adjustments (consisting of normal recurring adjustments unless otherwise indicated) which, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Certain information in footnote disclosures normally included in the financial statements prepared in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the SEC rules and regulations for interim reporting. The financial results for the periods presented may not be indicative of the full year&#8217;s results.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">These unaudited condensed financial statements should be read in conjunction with the Company&#8217;s audited consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2017 included in the Company&#8217;s Annual Report on Form 10-K filed on April 2, 2018.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Use of Estimates</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company&#8217;s condensed financial statements include certain amounts that are based on management&#8217;s best estimates and judgments. The Company&#8217;s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, fair value used in estimating the value of warrants, stock-based compensation, accrued expenses and provisions for income taxes. Due to the uncertainty inherent in such estimates, actual results may differ from these estimates.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Cash</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">As of September 30, 2018 and December 31, 2017, substantially all of the Company&#8217;s cash was held by major financial institutions and the balance at certain times may exceed the maximum amount insured by the Federal Deposits Insurance Corporation. However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Property and Equipment</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Lab equipment, leasehold improvements and office equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of each asset, generally three to seven years.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Impairment of Long-Lived Assets</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. There were no indicators of impairment for long-lived assets during the nine months ended September 30, 2018.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Fair Value of Preferred Stock</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 29.7pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The fair value of Preferred stock was estimated based upon equivalent common shares that Preferred Stock could have been converted into at the closing price on the purchase date.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Convertible Financial Instruments</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company bifurcates conversion options from their host instruments and accounts for them as free standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument. Deemed dividends are also recorded for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Research and Development</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. Upfront and milestone payments due to third parties that perform research and development services on the Company&#8217;s behalf will be expensed as services are rendered or when the milestone is achieved.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 17.6pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Research and development costs primarily consist of personnel related expenses, including salaries, benefits, travel, and other related expenses, stock-based compensation, payments made to third parties for license and milestone costs related to in-licensed products and technology, payments made to third party contract research organizations, consultants, the cost of acquiring and manufacturing research trial materials, and costs associated with regulatory filings, laboratory costs and other supplies.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 31.9pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In accordance with ASC 730-10-25-1, <i>Research and Development</i>, costs incurred in obtaining technology licenses are charged to research and development expense if the technology licensed has not reached commercial feasibility and has no alternative future use. Certain licenses purchased by the Company require substantial completion of research and development and regulatory and marketing approval efforts in order to reach commercial feasibility and have no alternative future use.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">During the nine months ended September 30, 2018, in addition to ongoing efforts at one major research university, the Company entered into additional contracts with a national research lab and another major research university for additional work related to development and scale-up of the Company&#8217;s processes. The Company also commenced research and development efforts at the Company&#8217;s Yonkers lab facility.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Contingencies</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records accruals for contingencies and legal proceedings expected to be incurred in connection with a loss contingency when it is probable that a liability has been incurred and the amount can be reasonably estimated.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">If a loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Stock-Based Compensation</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company expenses stock-based compensation to employees over the requisite service period based on the estimated grant-date fair value of the awards. For stock-based compensation awards to non-employees, the Company remeasures the fair value of the non-employee awards at each reporting period prior to vesting and finally at the vesting date of the award. Changes in the estimated fair value of these non-employee awards are recognized as compensation expense in the period of change.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company estimates the fair value of stock options grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management&#8217;s best estimates and involve inherent uncertainties and the application of management&#8217;s judgment.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Income Taxes</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 37.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Loss Per Share</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share excludes the potential impact of common stock options, convertible preferred stock and outstanding common stock purchase warrants because their effect would be anti-dilutive.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 15.4pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Warrants to purchase common stock</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,719,292</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,744,292</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Options to purchase common stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">16,024,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">8,880,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Preferred stock convertible into common stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,348,060</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt"><b>Total</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>23,091,352</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>13,624,292</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Non-Controlling Interests</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify; text-indent: 34.1pt">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third parties. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>Recent Accounting Pronouncements</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The Company considers the applicability and impact of all Accounting Standard Updates (&#8220;ASUs&#8221;). ASUs not discussed below were assessed and determined to be either not applicable or are expected to have minimal impact on our balance sheets or statements of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the Financial Accounting Standards Board (&#8220;FASB&#8221;) issued ASU 2018-13, &#8220;Fair Value Measurement (Topic 820), &#8211; Disclosure Framework &#8211; Changes to the Disclosure Requirements for Fair Value Measurement,&#8221; which makes a number of changes meant to add, modify or remove certain disclosure requirements associated with the movement amongst or hierarchy associated with Level 1, Level 2 and Level 3 fair value measurements. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the update. The Company is still evaluating but does not expect the adoption of this guidance to have a material impact on its condensed Financial Statements.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders&#8217; equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders&#8217; equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company plans to adopt this change in Q1 2019.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In June 2018, the FASB issued ASU 2018-07, &#8220;Improvements to Nonemployee Share-Based Payment Accounting&#8221;, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The changes take effect for public companies for fiscal years starting after December 15, 2018, including interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity&#8217;s adoption date of Topic 606. We are still evaluating but expect the adoption of this pronouncement will eliminate significant fluctuation in stock based compensation expensed in the past due to awards to non-employees.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception, (ASU 2017-11). Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company is currently assessing the potential impact of adopting ASU 2017-11 on its financial statements and related disclosures.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify"><b>&#160;</b></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In May 2017, the FASB issued ASU 2017-09, <i>Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting</i>, (ASU 2017-09). ASU 2017-09 provides clarity and reduces both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, to a change to the terms or conditions of a share-based payment award. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company adopted this ASU on January 1, 2018 and the adoption did not have a material impact on the Company&#8217;s financial position or results of operations.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) and subsequent amendments to the initial guidance: ASU 2017-13, ASU 2018-10 and ASU 2018-11 (collectively, Topic 842). Topic 842 requires companies to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. Topic 842 is effective for us in our first quarter of fiscal 2020, and earlier adoption is permitted. We are currently evaluating the impact of our pending adoption of Topic 842 on our consolidated financial statements. We currently expect that most of our operating lease commitments (see MD&#38;A for commitments) will be subject to the new standard and recognized as operating lease liabilities and right-of-use assets upon our adoption of Topic 842, which will increase our total assets and total liabilities that we report relative to such amounts prior to adoption.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases which clarifies, corrects or consolidates authoritative guidance issued in ASU 2016-02 and is effective upon adoption of ASU 2016-02. In July 2018, the FASB issued ASU 2018-11, Targeted Improvements, which provides an optional transition method that allows entities to elect to apply the standard prospectively at its effective date, versus recasting the prior periods presented. If elected, an entity would recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. The Company is still evaluating the method of adopting the standard.</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">&#160;</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company adopted the standard as of January 1, 2018 and adoption did not have a material impact on its condensed statement of cash flows.</p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows:</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>As of September 30,</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 62%"><font style="font-size: 10pt">Warrants to purchase common stock</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,719,292</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">4,744,292</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Options to purchase common stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">16,024,000</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">8,880,000</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Preferred stock convertible into common stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">2,348,060</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt; padding-left: 10pt"><font style="font-size: 10pt"><b>Total</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>23,091,352</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt"><b>13,624,292</b></font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The components of property and equipment as of September 30, 2018 and December 31, 2017, at cost are (dollars in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt">Useful Life (Years)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>September 30, 2018</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>December 31, 2017</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 41%"><font style="font-size: 10pt">Lab equipment</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">3</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 18%; text-align: right"><font style="font-size: 10pt">415</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 16%; text-align: right"><font style="font-size: 10pt">173</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Office furniture and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">3</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">31</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">31</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Leasehold improvement</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: right"><font style="font-size: 10pt">7</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">379</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">374</font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Gross property and equipment</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">825</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">578</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Less: Accumulated depreciation and amortization</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt; text-align: right">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(160</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(77</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Property and equipment, net</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt; text-align: right">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">665</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">501</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center">&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>For 20 consecutive business</b></font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>Total option shares that</b></font></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="text-align: center"><font style="font-size: 10pt"><b>Common stock price</b></font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>days, with average daily</b></font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt"><b>become vested on satisfaction</b></font></td></tr> <tr style="vertical-align: bottom"> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>closes at or above</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>volumn in excess of</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>of conditions</b></font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 1%; text-align: center"><font style="font-size: 10pt">$</font></td> <td style="width: 26%; text-align: right"><font style="font-size: 10pt">3.00</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 31%; text-align: center"><font style="font-size: 10pt">20,000</font></td> <td style="width: 1%">&#160;</td> <td style="width: 39%; text-align: center"><font style="font-size: 10pt">2,000,000 (28.5%)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="text-align: center"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">6.00</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">40,000</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">4,000,000 (51.7%)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="text-align: center"><font style="font-size: 10pt">$</font></td> <td style="text-align: right"><font style="font-size: 10pt">11.00</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">60,000</font></td> <td>&#160;</td> <td style="text-align: center"><font style="font-size: 10pt">7,000,000 (100.0%)</font></td></tr> </table> <p style="margin: 0pt"></p> <p style="margin: 0pt"></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: justify">The following table summarizes the Company&#8217;s Series A Preferred Stock activities for the nine months ended September 30, 2018 (dollars in thousands):</p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center">&#160;</p> <table cellspacing="0" cellpadding="0" style="font: 12pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse"> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="6" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Series A Preferred Stock</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom"> <td>&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Shares</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td colspan="2" style="border-bottom: black 1.5pt solid; text-align: center"><font style="font-size: 10pt"><b>Amount</b></font></td> <td style="padding-bottom: 1.5pt">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="width: 64%"><font style="font-size: 10pt">Total temporary equity as of December 31, 2017</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">1,935</font></td> <td style="width: 1%">&#160;</td> <td style="width: 1%">&#160;</td> <td style="width: 1%"><font style="font-size: 10pt">$</font></td> <td style="width: 15%; text-align: right"><font style="font-size: 10pt">1,935</font></td> <td style="width: 1%">&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Sale of Series A preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,700</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">1,700</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Conversion of advances into preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">250</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">250</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Preferred stock converted to common stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(55</font></td> <td><font style="font-size: 10pt">)</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(55</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Beneficial conversion feature of Series A preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">(956</font></td> <td><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Deemed dividends related to beneficial conversion feature of Series A preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">956</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td><font style="font-size: 10pt">Accrued Series A dividends</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">275</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">275</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: white"> <td><font style="font-size: 10pt">Deemed dividend on Series A preferred stock</font></td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">-</font></td> <td>&#160;</td> <td>&#160;</td> <td>&#160;</td> <td style="text-align: right"><font style="font-size: 10pt">687</font></td> <td>&#160;</td></tr> <tr style="vertical-align: bottom; background-color: #CCEEFF"> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">Fair Value of common stock warrant issued with Series A preferred stock</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">-</font></td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="padding-bottom: 1.5pt">&#160;</td> <td style="border-bottom: black 1.5pt solid">&#160;</td> <td style="border-bottom: black 1.5pt solid; text-align: right"><font style="font-size: 10pt">(687</font></td> <td style="padding-bottom: 1.5pt"><font style="font-size: 10pt">)</font></td></tr> <tr style="vertical-align: bottom; background-color: white"> <td style="padding-bottom: 2.5pt"><font style="font-size: 10pt">Total temporary equity as of September 30, 2018</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double">&#160;</td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4,105</font></td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="padding-bottom: 2.5pt">&#160;</td> <td style="border-bottom: black 2.25pt double"><font style="font-size: 10pt">$</font></td> <td style="border-bottom: black 2.25pt double; text-align: right"><font style="font-size: 10pt">4,105</font></td> <td style="padding-bottom: 2.5pt">&#160;</td></tr> </table> <p style="margin: 0pt"></p> 160000 77000 2.00 0.20 0.20 7884000 1830000 1680000 1705000 20000 40000 60000 67000 P4Y3M19D 1 -82000 -82000 1000 1000 1000 1000 -1000 -81000 -1000 -81000 100000 true false false 192000 2000 2000 55 EX-101.SCH 5 alpe-20180930.xsd XBRL SCHEMA FILE 00000001 - Document - Document and Entity Information link:presentationLink link:calculationLink link:definitionLink 00000002 - Statement - Condensed Balance Sheets link:presentationLink link:calculationLink link:definitionLink 00000003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000004 - Statement - Condensed Statements of Operations (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000005 - Statement - Condensed Statements of Operations (Unaudited) (Parenthetical) link:presentationLink link:calculationLink link:definitionLink 00000006 - Statement - Condensed Statement of Stockholders' Deficit (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000007 - Statement - Condensed Statements of Cash Flows (Unaudited) link:presentationLink link:calculationLink link:definitionLink 00000008 - Disclosure - Organization and Operations link:presentationLink link:calculationLink link:definitionLink 00000009 - Disclosure - Going Concern and Liquidity link:presentationLink link:calculationLink link:definitionLink 00000010 - Disclosure - Significant and Critical Accounting Policies and Practices link:presentationLink link:calculationLink link:definitionLink 00000011 - Disclosure - Property and Equipment link:presentationLink link:calculationLink link:definitionLink 00000012 - Disclosure - Related Party Transactions link:presentationLink link:calculationLink link:definitionLink 00000013 - Disclosure - Temporary Equity link:presentationLink link:calculationLink link:definitionLink 00000014 - Disclosure - Stockholders' (Deficit) Equity link:presentationLink link:calculationLink link:definitionLink 00000015 - Disclosure - Significant and Critical Accounting Policies and Practices (Policies) link:presentationLink link:calculationLink link:definitionLink 00000016 - Disclosure - Significant and Critical Accounting Policies and Practices (Tables) link:presentationLink link:calculationLink link:definitionLink 00000017 - Disclosure - Property and Equipment (Tables) link:presentationLink link:calculationLink link:definitionLink 00000018 - Disclosure - Related Party Transactions (Tables) link:presentationLink link:calculationLink link:definitionLink 00000019 - Disclosure - Temporary Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000020 - Disclosure - Stockholders' (Deficit) Equity (Tables) link:presentationLink link:calculationLink link:definitionLink 00000021 - Disclosure - Organization and Operations (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000022 - Disclosure - Going Concern and Liquidity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000023 - Disclosure - Significant and Critical Accounting Policies and Practices (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000024 - Disclosure - Significant and Critical Accounting Policies and Practices - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) link:presentationLink link:calculationLink link:definitionLink 00000025 - Disclosure - Property and Equipment (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000026 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) link:presentationLink link:calculationLink link:definitionLink 00000027 - Disclosure - Related Party Transactions (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000028 - Disclosure - Related Party Transactions - Schedule of Stock Price and Volume Milestones (Details) link:presentationLink link:calculationLink link:definitionLink 00000029 - Disclosure - Temporary Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000030 - Disclosure - Temporary Equity - Schedule of Temporary Equity (Details) link:presentationLink link:calculationLink link:definitionLink 00000031 - Disclosure - Stockholders' (Deficit) Equity (Details Narrative) link:presentationLink link:calculationLink link:definitionLink 00000032 - Disclosure - Stockholders' (Deficit) Equity - Schedule of Fair Value of Assumptions (Details) link:presentationLink link:calculationLink link:definitionLink 00000033 - Disclosure - Stockholders' (Deficit) Equity - Schedule of Stock Options, Activity (Details) link:presentationLink link:calculationLink link:definitionLink 00000034 - Disclosure - Stockholders' (Deficit) Equity - Schedule of Warrants Outstanding (Details) link:presentationLink link:calculationLink link:definitionLink 00000035 - Disclosure - Stockholders' (Deficit) Equity - Schedule of Stock-based Compensation Expense (Details) link:presentationLink link:calculationLink link:definitionLink EX-101.CAL 6 alpe-20180930_cal.xml XBRL CALCULATION FILE EX-101.DEF 7 alpe-20180930_def.xml XBRL DEFINITION FILE EX-101.LAB 8 alpe-20180930_lab.xml XBRL LABEL FILE Class of Stock [Axis] Common Class B [Member] Property, Plant and Equipment, Type [Axis] Lab Equipment [Member] Equity Components [Axis] Warrants to Purchase Common Stock [Member] Option Indexed to Issuer's Equity [Axis] Stock Option [Member] Office Furniture and Equipment [Member] Leasehold Improvement [Member] Award Type [Axis] Employee Stock Option Awards [Member] Non-Employee Stock Option Awards [Member] Title of Individual [Axis] Board of Directors [Member] Jerome I. Feldman [Member] Financial Instrument [Axis] Series A Preferred Stock [Member] Legal Entity [Axis] Clean Lithium Corporation [Member] Series A Preferred [Member] Range [Axis] Minimum [Member] Maximum [Member] Preferred Stock Convertible into Common Stock [Member] Steven M. Fludder [Member] Steven M. Payne [Member] Jim Kilman [Member] KielStrand Capital LLC [Member] Income Statement Location [Axis] Research and Development Expense [Member] Preferred Stock [Member] Pitroda Group LLC [Member] Related Party [Axis] Other Accredited and Institutional Investors [Member] Common Stock [Member] Additional Paid-In Capital [Member] Treasury Stock [Member] Accumulated Deficit [Member] Noncontrolling Interest [Member] Mr. Pitroda [Member] Valuation Approach and Technique [Axis] Valuation Technique, Option Pricing Model [Member] Measurement Input Type [Axis] Dividend Yield [Member] Risk Free Interest Rate [Member] Volatility [Member] Expected Term [Member] Steven Fludder [Member] Derivative Instrument [Axis] Vesting [Axis] Stock Option One [Member] Stock Option Two [Member] Stock Option Three [Member] Contractual Term [Member] Investor [Member] Stock Option One [Member] Sale of Stock [Axis] Private Placement [Member] Unvested Employee Stock Options [Member] Stock Options [Member] Type of Arrangement and Non-arrangement Transactions [Axis] Employment Agreement [Member] Series A Preferred Stock [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Entity Filer Category Entity Small Business Flag Entity Emerging Growth Company Entity Ex Transition Period Entity Common Stock, Shares Outstanding Trading Symbol Document Fiscal Period Focus Document Fiscal Year Focus Statement [Table] Statement [Line Items] ASSETS Current assets Cash Restricted cash Total current assets Long-term deposit Property and equipment, net Total assets LIABILITIES AND STOCKHOLDERS' DEFICIT AND TEMPORARY EQUITY Current liabilities Accounts payable and accrued expenses Advances from related parties Current portion of deferred rent Total current liabilities Deferred rent Total liabilities Preferred stock par value $0.01: 5,000,000 shares authorized; 4,105 shares and 1,935 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively; aggregate liquidation preference of $4,105 and $1,935 as of September 30, 2018 and December 31, 2017, respectively COMMITMENTS AND CONTINGENCIES Stockholders' deficit: Common stock value Additional paid-in capital Treasury stock at cost: 714,750 shares as of September 30, 2018 and December 31, 2017 Accumulated deficit Stockholders' deficit attributed to alpha-En Corporation stockholders Non-controlling interest Total stockholders' deficit TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT AND TEMPORARY EQUITY Preferred stock, par or stated value per share Preferred stock, shares authorized Preferred stock, shares issued Preferred stock, shares outstanding Preferred stock, liquidation preference Common stock, par or stated value per share Common stock, shares authorized Common stock, shares, issued Common stock, shares, outstanding Treasury stock, shares Income Statement [Abstract] Operating expenses General and administrative Legal and professional fees Research and development (includes stock based compensation of $(28) and $(245) for the three and nine months ended September 30, 2018, and $243 and $783 for the three and nine months ended September 30, 2017, respectively. See Note 7) Total operating expenses Other income (loss) Loss on extinguishment of accounts payable Other expenses Interest income Total other loss Net loss Less: net loss attributable to non-controlling interest Net loss attributable to controlling interest Less: Dividends accrued on preferred stock Less: Deemed dividend on Series A preferred stock Less: Deemed dividend - beneficial conversion feature on preferred stock Net loss attributable to alpha-En Corporation common stockholders Net loss per share attributable to alpha-En Corporation common stockholders Basic and diluted Weighted average shares outstanding: Basic and diluted Stock based compensation Balance Balance, shares Stock based compensation Stock based compensation, Shares Shares issued for acquiring ownership of subsidiary Shares issued for acquiring ownership of subsidiary, shares Issuance of common stock for cash in a private placement Issuance of common stock for cash in a private placement, shares Preferred stock converted to common stock Preferred stock converted to common stock, shares Options exercised for cash Options exercised for cash, shares Warrants exercised for cash Warrants exercised for cash, shares Issuance of warrants to purchase common stock associated with preferred stock offering Deemed dividend on Series A preferred stock Beneficial conversion feature of Series A preferred stock Deemed dividends related to beneficial conversion feature of Series A preferred stock Accrued Series A dividends Net loss Balance Balance, shares Statement of Cash Flows [Abstract] Cash flows from operating activities Adjustments to reconcile net loss to net cash used in operating activities: Depreciation and amortization Stock-based compensation Warrant issued for services Loss on extinguishment of accounts payable Changes in operating assets and liabilities of business, net of acquisitions: Prepaid expenses Accounts payable and accrued expenses Deferred rent Net cash used in operating activities Cash flows from investing activities Release of restricted cash and long term deposit Purchase of fixed assets Net cash (used in) provided by investing activities Cash flows from financing activities Proceeds from issuance of preferred stock and warrants Proceeds from issuance of common stock in a private placement Options exercised for cash Warrants exercised for cash Advances from related parties Repayments of advances from related parties Net cash provided by financing activities Net increase in cash Cash and restricted cash at beginning of period Cash and restricted cash at end of period Non cash financing and investing activities: Beneficial conversion feature of Series A preferred stock Deemed dividends related to beneficial conversion feature of Series A preferred stock Issuance of warrants in preferred stock offering Deemed dividend on Series A preferred stock Accrued Series A dividends Conversion of advances from related parties to preferred stock Common stock and warrants issued for extinguishment of accounts payable Preferred stock converted to common stock Purchases of fixed assets in accounts payable Forgiveness of the lease payments Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization and Operations Going Concern and Liquidity Accounting Policies [Abstract] Significant and Critical Accounting Policies and Practices Property, Plant and Equipment [Abstract] Property and Equipment Related Party Transactions [Abstract] Related Party Transactions Temporary Equity [Abstract] Temporary Equity Equity [Abstract] Stockholders' (Deficit) Equity Basis of Presentation and Principles of Consolidation Use of Estimates Cash Property and Equipment Impairment of Long-Lived Assets Fair Value of Preferred Stock Convertible Financial Instruments Research and Development Contingencies Stock-Based Compensation Income Taxes Loss Per Share Non-Controlling Interests Recent Accounting Pronouncements Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share Schedule of Property and Equipment Schedule of Stock Price and Volume Milestones Schedule of Temporary Equity Schedule of Fair Value of Assumptions Schedule of Stock Options, Activity Schedule of Warrants Outstanding Schedule of Stock-based Compensation Expense Schedule of Franchisor Disclosure [Table] Franchisor Disclosure [Line Items] Report Date [Axis] Capital Equity ownership percentage Number of common stock issued, shares Issued and outstanding voting stock, percentage Capital stock authorized Common stock share authorized Common stock, par value Preferred stock shares authorized Preferred stock, par value Accumulated deficit Net loss Net cash used in operating activities Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Ownership percentage Estimated useful life Impairment for long-lived assets Increase in prepaid expenses Antidilutive Securities [Axis] Antidilutive securities excluded from computation of earnings per share, amount Property, Plant and Equipment [Table] Property, Plant and Equipment [Line Items] Property, plant and equipment, useful life Gross property and equipment Less: Accumulated depreciation and amortization Property and equipment, net Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] Repayments of related party debt Conversion into stock Stock option to purchase common stock Exercise price per share Share based compensation option expires in period Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value Fair value assumptions, measurement input, percentages Fair value assumptions, measurement input, term Amortize option over its service period Share based compensation Number of shares under vested options were forfeited Common stock price closes at or above For 20 consecutive business days, with average daily volume in excess of Total option shares that become vested on satisfaction of conditions Total option shares that become vested on satisfaction of conditions, vesting percentage Schedule of Stock by Class [Table] Number of preferred stock shares issue Warrant purchase of common stock, shares Purchase price per share Gross proceeds from issuance of preferred stock Warrants term Warrants exercise price Number of preferred stock converted into shares of common stock Invested amount Preferred stock shares issued Preferred stock dividend rate Original issue price Number of common stock issued, shares Warrants fair value Preferred stock fair value Preferred stock conversion basis Preferred stock beneficial conversion feature Number of preferred stock converted into shares of common stock, shares Dividend accrued and outstanding Total temporary equity, shares beginning Total temporary equity, beginning Sale of Series A preferred stock, shares Sale of Series A preferred stock Conversion of advances into preferred stock, shares Conversion of advances into preferred stock Beneficial conversion feature of Series A preferred stock Deemed dividends related to beneficial conversion feature of Series A preferred stock Accrued Series A dividends, shares Deemed dividend on Series A preferred stock Fair Value of common stock warrant issued with Series A preferred stock Total temporary equity, shares ending Total temporary equity, ending Stock based compensation expense relating to unvested Fair value of stock option granted Amortized period Exercise price Expected stock price volatility Risk-free rate of interest Term (years) Number of Shares, Outstanding, Beginning Balance Number of Shares, Options granted Number of Shares, Options Exercised Number of Shares, Expired Number of Shares, Outstanding, Ending Balance Number of Shares, Options vested and expected to vest Number of Shares, Options vested and exercisable Weighted Average Exercise Price, Outstanding, Beginning Balance Weighted Average Exercise Price, Options granted Weighted Average Exercise Price, Options Exercised Weighted Average Exercise Price, Expired Weighted Average Exercise Price, Outstanding, Ending Balance Weighted Average Exercise Price, Options vested and expected to vest Weighted Average Exercise Price, Options vested and exercisable Intrinsic Value, Outstanding, Beginning Balance Intrinsic Value, Options granted Intrinsic Value, Options exercised Intrinsic Value, Options expired Intrinsic Value, Outstanding, Ending Balance Intrinsic Value, Options vested and expected to vest Intrinsic Value, Options vested and exercisable Weighted Average Remaining Contractual Life (in years), Outstanding, Beginning Balance Weighted Average Remaining Contractual Life (in years), Options granted Weighted Average Remaining Contractual Life (in years), Options Exercised Weighted Average Remaining Contractual Life (in years), Options Expired Weighted Average Remaining Contractual Life (in years), Outstanding, Ending Balance Weighted Average Remaining Contractual Life (in years), Options vested and expected to vest Weighted Average Remaining Contractual Life (in years), Options vested and exercisable Number of Warrant, Beginning Number of Warrant, Issued Number of Warrant, Exercised Number of Warrant, Ending Number of Warrants, Warrants exercisable Weighted Average Exercise Price, Outstanding, Beginning Balance Weighted Average Exercise Price, Issued Weighted Average Exercise Price, Exercised Weighted Average Exercise Price, Outstanding, Ending Balance Weighted Average Exercise Price, Warrants exercisable Intrinsic Value, Outstanding, Beginning Balance Intrinsic Value, Issued Intrinsic Value, Exercised Intrinsic Value, Outstanding, Ending Balance Intrinsic Value, Warrants exercisable Weighted Average Remaining Contractual Life (in years), Outstanding, Beginning Balance Weighted Average Remaining Contractual Life (in years), Issued Weighted Average Remaining Contractual Life (in years), Exercised Weighted Average Remaining Contractual Life (in years), Outstanding, Ending Balance Weighted Average Remaining Contractual Life (in years), Warrants exercisable Share-based Compensation Accrued Series A dividends. Accrued Series A dividends, shares. Amortized period. Basis of Presentation and Principles of Consolidation [Policy Text Block] Beneficial conversion feature of Series A preferred stock. Beneficial conversion feature of Series A preferred stock1. Board of Directors [Member] Clean Lithium Corporation [Member] Conversion of advances from related parties to preferred stock. Conversion of advances into preferred stock. Conversion of advances into preferred stock, shares. Convertible Financial Instruments [Policy Text Block] Deemed dividend on Series A preferred stock. Employee Stock Option Awards [Member] Fair Value of common stock warrant issued with Series A preferred stock. Fair Value of Preferred Stock [Policy text Block] Intrinsic Value, Options expired. Issuance of warrants in preferred stock offering. Issued and outstanding voting stock, percentage. Jerome I. Feldman [Member] Jim Kilman [Member] Lab Equipment [Member] Leasehold Improvement [Member] Non Employee Stock Option Awards [Member] Disclosure of accounting policy for non controlling interests. Office Furniture Equipment [Member] Original issue price Other Accredited and Institutional Investors [Member] Pitroda Group LLC [Member] Total temporary equity, shares beginning. Total temporary equity, ending. Sale of Series A preferred stock. Sale of Series A preferred stock, shares. Tabular disclosure of information related warrants activity. Series A Preferred [Member] Share based compensation arrangement by share based payment award equity instruments other than options nonvested number. Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are exercisable as of the balance sheet date. Intrinsic value of equity-based compensation awards warrants exercisable. Excludes stock and unit options. Weighted average remaining contractual term for equity-based awards exercisable excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Intrinsic value of equity-based compensation awards granted. Excludes stock and unit options. The weighted average exercise price of non-vested equity-based payment instruments, excluding stock (or unit) options, granted during the period. Weighted average remaining contractual term for equity-based awards granted excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. The weighted average exercise price of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are exercisable as of the balance sheet date. The weighted average exercise price of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Weighted average remaining contractual term for options granted, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Amount of accumulated difference between fair value of underlying shares on dates of grant. Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Steven M. Fludder [Member] Steven M. Payne [Member] Temporary Equity [Text Block] Warrant issued for service. Warrants term. Weighted Average Remaining Contractual Life (in years), Options Exercised. Weighted Average Remaining Contractual Life (in years), Options Expired. Issuance of warrants to purchase common stock associated with preferred stock offering. Deemed dividends related to beneficial conversion feature of Series A preferred stock. Warrants exercised for cash. Warrants exercised for cash, shares. Preferred stock converted to common stock. Forgiveness of the lease payments. Schedule of stock price and volume milestones [Table Text Block] Preferred Stock Convertible into Common Stock [Member] Fair value assumptions, measurement input, percentages. Fair value assumptions, measurement input, term. Mr. Pitroda [Member] The amount of grant-date fair value of options granted during the reporting period. Steven Fludder [Member] KielStrand Capital LLC [Member] The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are exercisable as of the balance sheet date. Intrinsic value of equity-based compensation awards granted. Excludes stock and unit options. Weighted average remaining contractual term for equity-based awards granted excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. The weighted average exercise price of non-vested equity-based payment instruments, excluding stock (or unit) options, granted during the period. Stock Option One [Member] consecutive business days, with average daily volume in excess. Purchase of fixed assets in accounts payable. Unvested Employee Stock Options [Member] Stock Options [Member] Release of restricted cash and long term deposit. Alpha-En Corporation [Member] Vendors in Lieu [Member] Common stock and warrants issued for extinguishment of accounts payable. Employment Agreement [Member] Series A Preferred Stock [Member] StockOptionOneMember SeriesAPreferredStockOneMember Assets, Current Assets Liabilities, Current Liabilities Treasury Stock, Value Stockholders' Equity Attributable to Parent Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest Liabilities and Equity Operating Expenses Other Expenses Nonoperating Income (Expense) Net Income (Loss) Attributable to Parent Preferred Stock Dividends, Income Statement Impact Redeemable Preferred Stock Dividends Other Preferred Stock Dividends and Adjustments Net Income (Loss) Available to Common Stockholders, Basic Weighted Average Number of Shares Outstanding, Basic and Diluted Shares, Outstanding Stock Issued During Period, Value, Share-based Compensation, Net of Forfeitures Dividends, Preferred Stock Increase (Decrease) in Accounts Payable and Accrued Liabilities Increase (Decrease) in Deferred Liabilities Net Cash Provided by (Used in) Operating Activities Payments to Acquire Property, Plant, and Equipment Net Cash Provided by (Used in) Investing Activities Proceeds from Stock Options Exercised Proceeds from Warrant Exercises Proceeds from Related Party Debt Net Cash Provided by (Used in) Financing Activities Cash and Cash Equivalents, Period Increase (Decrease) Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents Clean Lithium Corporation [Member] [Default Label] PreferredStockConvertedToCommonStock Cash and Cash Equivalents, Policy [Policy Text Block] Property, Plant and Equipment, Policy [Policy Text Block] Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Exercisable, Weighted Average Remaining Contractual Terms Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options Exercisable, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value [Default Label] Dividends, Preferred Stock, Stock Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Number Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Exercise Price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Outstanding Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Outstanding, Weighted Average Remaining Contractual Terms ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsOutstandingWeightedAverageRemainingContractualTerms1 EX-101.PRE 9 alpe-20180930_pre.xml XBRL PRESENTATION FILE XML 10 R1.htm IDEA: XBRL DOCUMENT v3.10.0.1
Document and Entity Information - shares
9 Months Ended
Sep. 30, 2018
Nov. 13, 2018
Document And Entity Information    
Entity Registrant Name alpha-En Corp  
Entity Central Index Key 0001023298  
Document Type 10-Q  
Document Period End Date Sep. 30, 2018  
Amendment Flag false  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business Flag true  
Entity Emerging Growth Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   39,044,589
Trading Symbol ALPE  
Document Fiscal Period Focus Q3  
Document Fiscal Year Focus 2018  
XML 11 R2.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Balance Sheets - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Current assets    
Cash $ 1,064 $ 562
Restricted cash 15 15
Total current assets 1,079 577
Long-term deposit 35 35
Property and equipment, net 665 501
Total assets 1,779 1,113
Current liabilities    
Accounts payable and accrued expenses 617 1,103
Advances from related parties 36 308
Current portion of deferred rent 9
Total current liabilities 662 1,411
Deferred rent 109
Total liabilities 771 1,411
Preferred stock par value $0.01: 5,000,000 shares authorized; 4,105 shares and 1,935 shares issued and outstanding as of September 30, 2018 and December 31, 2017, respectively; aggregate liquidation preference of $4,105 and $1,935 as of September 30, 2018 and December 31, 2017, respectively 4,105 1,935
COMMITMENTS AND CONTINGENCIES
Stockholders' deficit:    
Common stock value 390 334
Additional paid-in capital 21,301 18,482
Treasury stock at cost: 714,750 shares as of September 30, 2018 and December 31, 2017 (69) (69)
Accumulated deficit (24,719) (20,276)
Stockholders' deficit attributed to alpha-En Corporation stockholders (3,097) (1,529)
Non-controlling interest (704)
Total stockholders' deficit (3,097) (2,233)
TOTAL LIABILITIES AND STOCKHOLDERS' DEFICIT AND TEMPORARY EQUITY 1,779 1,113
Common Class B [Member]    
Stockholders' deficit:    
Common stock value
XML 12 R3.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Balance Sheets (Parenthetical) - USD ($)
$ in Thousands
Sep. 30, 2018
Dec. 31, 2017
Preferred stock, par or stated value per share $ 0.01 $ 0.01
Preferred stock, shares authorized 5,000,000 5,000,000
Preferred stock, shares issued 4,105 1,935
Preferred stock, shares outstanding 4,105 1,935
Preferred stock, liquidation preference $ 4,105 $ 1,935
Common stock, par or stated value per share $ 0.01 $ 0.01
Common stock, shares authorized 57,000,000 57,000,000
Common stock, shares, issued 39,044,589 33,350,506
Common stock, shares, outstanding 38,329,839 32,635,756
Treasury stock, shares 714,750 714,750
Common Class B [Member]    
Common stock, par or stated value per share
Common stock, shares authorized 1,000,000 1,000,000
Common stock, shares, issued
Common stock, shares, outstanding
XML 13 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Operating expenses        
General and administrative $ 1,213 $ 1,751 $ 3,396 $ 3,188
Legal and professional fees 103 135 364 390
Research and development (includes stock based compensation of $(28) and $(245) for the three and nine months ended September 30, 2018, and $243 and $783 for the three and nine months ended September 30, 2017, respectively. See Note 7) 372 473 837 1,093
Total operating expenses 1,688 2,359 4,597 4,671
Other income (loss)        
Loss on extinguishment of accounts payable (82) (82)
Other expenses (2) (2)
Interest income 1 1 1 1
Total other loss (1) (81) (1) (81)
Net loss (1,689) (2,440) (4,598) (4,752)
Less: net loss attributable to non-controlling interest (125) (155) (250)
Net loss attributable to controlling interest (1,689) (2,315) (4,443) (4,502)
Less: Dividends accrued on preferred stock (100) (46) (275) (68)
Less: Deemed dividend on Series A preferred stock (687) (649)
Less: Deemed dividend - beneficial conversion feature on preferred stock (956) (807)
Net loss attributable to alpha-En Corporation common stockholders $ (1,789) $ (2,361) $ (6,361) $ (6,026)
Net loss per share attributable to alpha-En Corporation common stockholders        
Basic and diluted $ (0.05) $ (0.07) $ (0.18) $ (0.18)
Weighted average shares outstanding:        
Basic and diluted 35,890,676 33,337,722 35,693,698 33,300,837
XML 14 R5.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Operations (Unaudited) (Parenthetical) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Stock based compensation $ 840 $ 1,640 $ 1,932 $ 2,706
Research and Development Expense [Member]        
Stock based compensation $ (28) $ 243 $ (245) $ 783
XML 15 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statement of Stockholders' Deficit (Unaudited) - 9 months ended Sep. 30, 2018 - USD ($)
$ in Thousands
Common Stock [Member]
Additional Paid-In Capital [Member]
Treasury Stock [Member]
Accumulated Deficit [Member]
Noncontrolling Interest [Member]
Total
Balance at Dec. 31, 2017 $ 334 $ 18,482 $ (69) $ (20,276) $ (704) $ (2,233)
Balance, shares at Dec. 31, 2017 33,350,506   714,750      
Stock based compensation 1,932 1,932
Stock based compensation, Shares          
Shares issued for acquiring ownership of subsidiary $ 30 (889) 859
Shares issued for acquiring ownership of subsidiary, shares 3,018,190          
Issuance of common stock for cash in a private placement $ 15 1,785 1,800
Issuance of common stock for cash in a private placement, shares 1,534,433          
Preferred stock converted to common stock 55 55
Preferred stock converted to common stock, shares 31,460          
Options exercised for cash $ 1 21 22
Options exercised for cash, shares 110,000          
Warrants exercised for cash $ 10 190 200
Warrants exercised for cash, shares 1,000,000          
Issuance of warrants to purchase common stock associated with preferred stock offering 687 687
Deemed dividend on Series A preferred stock (687) (687)
Beneficial conversion feature of Series A preferred stock 956 956
Deemed dividends related to beneficial conversion feature of Series A preferred stock (956) (956)
Accrued Series A dividends (275) (275)
Net loss (4,443) (155) (4,598)
Balance at Sep. 30, 2018 $ 390 $ 21,301 $ (69) $ (24,719) $ (3,097)
Balance, shares at Sep. 30, 2018 39,044,589   714,750      
XML 16 R7.htm IDEA: XBRL DOCUMENT v3.10.0.1
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Cash flows from operating activities    
Net loss $ (4,598) $ (4,752)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 83 41
Stock-based compensation 1,932 2,706
Warrant issued for services 249
Loss on extinguishment of accounts payable 82
Changes in operating assets and liabilities of business, net of acquisitions:    
Prepaid expenses 2
Accounts payable and accrued expenses (553) 62
Deferred rent 118
Net cash used in operating activities (3,018) (1,610)
Cash flows from investing activities    
Release of restricted cash and long term deposit 100
Purchase of fixed assets (180) (25)
Net cash (used in) provided by investing activities (180) 75
Cash flows from financing activities    
Proceeds from issuance of preferred stock and warrants 1,700 1,670
Proceeds from issuance of common stock in a private placement 1,800
Options exercised for cash 22
Warrants exercised for cash 200
Advances from related parties 150
Repayments of advances from related parties (22) (42)
Net cash provided by financing activities 3,700 1,778
Net increase in cash 502 243
Cash and restricted cash at beginning of period 562 442
Cash and restricted cash at end of period 1,064 685
Non cash financing and investing activities:    
Beneficial conversion feature of Series A preferred stock 956 807
Deemed dividends related to beneficial conversion feature of Series A preferred stock (956) (807)
Issuance of warrants in preferred stock offering 687 649
Deemed dividend on Series A preferred stock (687) (649)
Accrued Series A dividends (275) (68)
Conversion of advances from related parties to preferred stock 250 150
Common stock and warrants issued for extinguishment of accounts payable 192
Preferred stock converted to common stock 55
Purchases of fixed assets in accounts payable 67
Forgiveness of the lease payments $ 104
XML 17 R8.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Operations
9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Organization and Operations

Note 1 - Organization and Operations

 

alpha-En Corporation (the “Company”) was incorporated in Delaware on March 7, 1997.

 

Since 2008, the focus of the Company’s business has been developing new technologies for manufacturing highly pure lithium metal, a raw material for use in lightweight, high energy density batteries, in an environmentally friendly manner for commercial purposes. In 2013, the Company invented a new process for the production of highly pure lithium metal and associated products at room temperature. The Company subsequently broadened its focus to develop products and processes derived from the Company’s new core proprietary technology, including battery components and compounds of lithium.

 

Ownership of Subsidiary

 

In September 2014, alpha-En Corporation formed Clean Lithium Corporation (“CLC”) under the laws of New York State as a wholly owned subsidiary with a nominal share capital of $100,000. From 2014 to 2016, the Company sold 9.05% or 905,000 of CLC’s shares to minority equity holders. Effective as of June 14, 2018, the Company completed the purchase all of the outstanding shares of CLC such that CLC became a wholly-owned subsidiary of the Company and was immediately thereafter merged with and into the Company, with the Company surviving. In connection with this transaction, the former minority equity holders of CLC prior to the merger received an aggregate total of 3,018,190 shares of common stock of the Company. The Company recorded the acquisition of CLC as a capital transaction.

 

Amended and Restated Certificate of Incorporation

 

On March 29, 2017 the Board of Directors of the Company and a subset of the Company’s stockholders representing in excess of 75% of the Company’s currently issued and outstanding voting stock approved of the amendment and restatement of the Company’s Certificate of Incorporation (the “Restated Certificate”) to make certain corporate governance updates and to increase the authorized capital stock of the Company to 60,000,000 shares, of which 57,000,000 are shares of Common Stock, par value $0.01 per share, 1,000,000 are shares of Class B Common Stock, par value $0.01 per share and 2,000,000 are shares of preferred stock, par value $0.01 per share. The Company filed a definitive information statement on Schedule 14C with the Securities and Exchange Commission on June 1, 2017 describing the changes in the Restated Certificate. The Restated Certificate was filed with the Secretary of State for the State of Delaware and became effective on June 30, 2017. On February 8, 2018 the Company filed with the Secretary of State of the State of Delaware an amended and restated certificate of incorporation increasing the authorized number of preferred shares designated as series A preferred from 2,000 to 5,000.

XML 18 R9.htm IDEA: XBRL DOCUMENT v3.10.0.1
Going Concern and Liquidity
9 Months Ended
Sep. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Going Concern and Liquidity

Note 2 - Going Concern and Liquidity

 

The Company’s condensed financial statements have been prepared assuming that it will continue as a going concern, which contemplates continuity of operations, realization of assets, and liquidation of liabilities in the normal course of business.

 

As reflected in the condensed financial statements, the Company had an accumulated deficit of approximately $24.7 million at September 30, 2018, a net loss of approximately $4.6 million and approximately $3.0 million net cash used in operating activities for the nine months ended September 30, 2018. These factors raise substantial doubt about the Company’s ability to continue as a going concern.

 

The Company is attempting to further develop the intellectual property associated with its technology; broaden its patent portfolio; scale up its production of various products; and begin generating revenue; however, the Company’s cash position is not sufficient to support its daily operations for the foreseeable future. The ability of the Company to continue as a going concern is dependent upon its ability to raise additional funds by way of a public or private offering and its ability to further develop its technology and generate sufficient revenue. While the Company believes in the viability of its technology and in its ability to raise additional funds by way of a public or private offering, there can be no assurances to that effect.

 

The condensed financial statements do not include any adjustments related to the recoverability and classification of recorded asset amounts or the amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.

XML 19 R10.htm IDEA: XBRL DOCUMENT v3.10.0.1
Significant and Critical Accounting Policies and Practices
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Significant and Critical Accounting Policies and Practices

Note 3 - Significant and Critical Accounting Policies and Practices

 

Basis of Presentation and Principles of Consolidation

 

On June 14, 2018 the Company completed the purchase all of the outstanding shares of CLC such that CLC became a wholly-owned subsidiary of the Company and was immediately thereafter merged with and into the Company, with the Company surviving. Accordingly, as of June 14, 2018 the Company no longer has any subsidiaries consolidated in these financial statements.

 

For the year ended December 31, 2017 and through June 14, 2018, the accompanying condensed consolidated financial statements include the accounts of the Company’s subsidiaries. For consolidated entities where the Company owns less than 100% of the subsidiary, the Company records net loss attributable to non-controlling interests in its condensed consolidated statements of operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties.

 

The condensed consolidated balance at December 31, 2017 was derived from audited annual financial statements but do not contain all of the footnote disclosures from the annual financial statements. The unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments (consisting of normal recurring adjustments unless otherwise indicated) which, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented.

 

Certain information in footnote disclosures normally included in the financial statements prepared in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the SEC rules and regulations for interim reporting. The financial results for the periods presented may not be indicative of the full year’s results.

 

These unaudited condensed financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2017 included in the Company’s Annual Report on Form 10-K filed on April 2, 2018.

 

Use of Estimates

 

The Company’s condensed financial statements include certain amounts that are based on management’s best estimates and judgments. The Company’s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, fair value used in estimating the value of warrants, stock-based compensation, accrued expenses and provisions for income taxes. Due to the uncertainty inherent in such estimates, actual results may differ from these estimates.

 

Cash

 

As of September 30, 2018 and December 31, 2017, substantially all of the Company’s cash was held by major financial institutions and the balance at certain times may exceed the maximum amount insured by the Federal Deposits Insurance Corporation. However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.

 

Property and Equipment

 

Lab equipment, leasehold improvements and office equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of each asset, generally three to seven years.

 

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. There were no indicators of impairment for long-lived assets during the nine months ended September 30, 2018.

 

Fair Value of Preferred Stock

 

The fair value of Preferred stock was estimated based upon equivalent common shares that Preferred Stock could have been converted into at the closing price on the purchase date.

 

Convertible Financial Instruments

 

The Company bifurcates conversion options from their host instruments and accounts for them as free standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.

 

When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument. Deemed dividends are also recorded for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.

 

Research and Development

 

Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. Upfront and milestone payments due to third parties that perform research and development services on the Company’s behalf will be expensed as services are rendered or when the milestone is achieved.

 

Research and development costs primarily consist of personnel related expenses, including salaries, benefits, travel, and other related expenses, stock-based compensation, payments made to third parties for license and milestone costs related to in-licensed products and technology, payments made to third party contract research organizations, consultants, the cost of acquiring and manufacturing research trial materials, and costs associated with regulatory filings, laboratory costs and other supplies.

 

In accordance with ASC 730-10-25-1, Research and Development, costs incurred in obtaining technology licenses are charged to research and development expense if the technology licensed has not reached commercial feasibility and has no alternative future use. Certain licenses purchased by the Company require substantial completion of research and development and regulatory and marketing approval efforts in order to reach commercial feasibility and have no alternative future use.

 

During the nine months ended September 30, 2018, in addition to ongoing efforts at one major research university, the Company entered into additional contracts with a national research lab and another major research university for additional work related to development and scale-up of the Company’s processes. The Company also commenced research and development efforts at the Company’s Yonkers lab facility.

 

Contingencies

 

The Company records accruals for contingencies and legal proceedings expected to be incurred in connection with a loss contingency when it is probable that a liability has been incurred and the amount can be reasonably estimated.

 

If a loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.

 

Stock-Based Compensation

 

The Company expenses stock-based compensation to employees over the requisite service period based on the estimated grant-date fair value of the awards. For stock-based compensation awards to non-employees, the Company remeasures the fair value of the non-employee awards at each reporting period prior to vesting and finally at the vesting date of the award. Changes in the estimated fair value of these non-employee awards are recognized as compensation expense in the period of change.

 

The Company estimates the fair value of stock options grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment.

 

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

 

Loss Per Share

 

Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share excludes the potential impact of common stock options, convertible preferred stock and outstanding common stock purchase warrants because their effect would be anti-dilutive.

 

Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows:

 

    As of September 30,  
    2018     2017  
Warrants to purchase common stock     4,719,292       4,744,292  
Options to purchase common stock     16,024,000       8,880,000  
Preferred stock convertible into common stock     2,348,060       -  
Total     23,091,352       13,624,292  

 

Non-Controlling Interests

 

Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third parties. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests.

 

Recent Accounting Pronouncements

 

The Company considers the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not discussed below were assessed and determined to be either not applicable or are expected to have minimal impact on our balance sheets or statements of operations.

 

In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-13, “Fair Value Measurement (Topic 820), – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement,” which makes a number of changes meant to add, modify or remove certain disclosure requirements associated with the movement amongst or hierarchy associated with Level 1, Level 2 and Level 3 fair value measurements. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the update. The Company is still evaluating but does not expect the adoption of this guidance to have a material impact on its condensed Financial Statements.

 

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company plans to adopt this change in Q1 2019.

 

In June 2018, the FASB issued ASU 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The changes take effect for public companies for fiscal years starting after December 15, 2018, including interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity’s adoption date of Topic 606. We are still evaluating but expect the adoption of this pronouncement will eliminate significant fluctuation in stock based compensation expensed in the past due to awards to non-employees.

 

In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception, (ASU 2017-11). Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company is currently assessing the potential impact of adopting ASU 2017-11 on its financial statements and related disclosures.

 

In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting, (ASU 2017-09). ASU 2017-09 provides clarity and reduces both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, to a change to the terms or conditions of a share-based payment award. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company adopted this ASU on January 1, 2018 and the adoption did not have a material impact on the Company’s financial position or results of operations.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) and subsequent amendments to the initial guidance: ASU 2017-13, ASU 2018-10 and ASU 2018-11 (collectively, Topic 842). Topic 842 requires companies to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. Topic 842 is effective for us in our first quarter of fiscal 2020, and earlier adoption is permitted. We are currently evaluating the impact of our pending adoption of Topic 842 on our consolidated financial statements. We currently expect that most of our operating lease commitments (see MD&A for commitments) will be subject to the new standard and recognized as operating lease liabilities and right-of-use assets upon our adoption of Topic 842, which will increase our total assets and total liabilities that we report relative to such amounts prior to adoption.

 

In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases which clarifies, corrects or consolidates authoritative guidance issued in ASU 2016-02 and is effective upon adoption of ASU 2016-02. In July 2018, the FASB issued ASU 2018-11, Targeted Improvements, which provides an optional transition method that allows entities to elect to apply the standard prospectively at its effective date, versus recasting the prior periods presented. If elected, an entity would recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. The Company is still evaluating the method of adopting the standard.

 

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company adopted the standard as of January 1, 2018 and adoption did not have a material impact on its condensed statement of cash flows.

XML 20 R11.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment
9 Months Ended
Sep. 30, 2018
Property, Plant and Equipment [Abstract]  
Property and Equipment

Note 4 - Property and Equipment

 

The components of property and equipment as of September 30, 2018 and December 31, 2017, at cost are (dollars in thousands):

 

    Useful Life (Years)     September 30, 2018     December 31, 2017  
Lab equipment     3     $ 415     $ 173  
Office furniture and equipment     3       31       31  
Leasehold improvement     7       379       374  
Gross property and equipment             825       578  
Less: Accumulated depreciation and amortization             (160 )     (77 )
Property and equipment, net           $ 665     $ 501  

 

The Company’s depreciation and amortization expense for the three and nine months ended September 30, 2018 was $32,000 and $83,000, and $24,000 and $41,000 for the three and nine months ended September 30, 2017, respectively.

XML 21 R12.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions
9 Months Ended
Sep. 30, 2018
Related Party Transactions [Abstract]  
Related Party Transactions

Note 5 - Related Party Transactions

 

Advances from Stockholders

 

From time to time, stockholders of the Company advances funds to the Company for working capital purposes. Those advances are unsecured, non-interest bearing and due on demand.

 

As of September 30, 2018 and December 31, 2017, the outstanding amounts of the advances from related parties was approximately $36,000 and $308,000, respectively. During the nine months ended September 30, 2018, the Company repaid $15,000 in advances to Jerome Feldman and $7,000 to Steven Fludder and $250,000 was converted into preferred stock. See Note 6 for more details on advances converted to preferred stock.

 

Employment Agreement with Chief Executive Officer

 

On November 11, 2017, the Company appointed Sam Pitroda to serve as the Company’s new Chief Executive Officer. Since that time, Mr. Pitroda has served as CEO without an employment agreement. The Company and Mr. Pitroda are in discussions to finalize the terms of the employment agreement, although there can be no assurances that an agreement will be reached. On May 31, 2018, the board of directors approved to grant Mr. Pitroda an option to purchase 7,000,000 shares of the Company’s common stock at an exercise price of $2.08 per share. The option expires seven years from the option grant date. The stock subject to the option will vest upon the earlier to occur of (1) the five-year anniversary of the option grant date or (2) the achievement of certain stock price and volume milestones, which are as follows:

 

      For 20 consecutive business   Total option shares that
Common stock price     days, with average daily   become vested on satisfaction
closes at or above     volumn in excess of   of conditions
$ 3.00     20,000   2,000,000 (28.5%)
$ 6.00     40,000   4,000,000 (51.7%)
$ 11.00     60,000   7,000,000 (100.0%)

 

The total fair value of this option award on the grant date was approximately $7.6 million. The fair value of the option award was determined using the Black-Scholes model with the following assumptions: risk free interest rate – 2.7%, volatility – 78.0%, expected term – 4 years and dividends– N/A. The Company will amortize the option over its service period of 4.09 years which was derived from a Monte Carlo simulation. Stock-based compensation expense for this option recognized for the three and nine months ended September 30, 2018 was $466,000 and $622,000, respectively.

 

On September 1 2017, Steven Fludder, former CEO, resigned from the Company. On June 22, 2018, the Company vested 150,000 stock options that would have been forfeited. The Company recorded additional stock compensation expense of $210,000 related to this stock option modification.

XML 22 R13.htm IDEA: XBRL DOCUMENT v3.10.0.1
Temporary Equity
9 Months Ended
Sep. 30, 2018
Temporary Equity [Abstract]  
Temporary Equity

Note 6 - Temporary Equity

 

The following table summarizes the Company’s Series A Preferred Stock activities for the nine months ended September 30, 2018 (dollars in thousands):

 

    Series A Preferred Stock  
    Shares     Amount  
Total temporary equity as of December 31, 2017     1,935     $ 1,935  
Sale of Series A preferred stock     1,700       1,700  
Conversion of advances into preferred stock     250       250  
Preferred stock converted to common stock     (55 )     (55 )
Beneficial conversion feature of Series A preferred stock     -       (956 )
Deemed dividends related to beneficial conversion feature of Series A preferred stock     -       956  
Accrued Series A dividends     275       275  
Deemed dividend on Series A preferred stock     -       687  
Fair Value of common stock warrant issued with Series A preferred stock     -       (687 )
Total temporary equity as of September 30, 2018     4,105     $ 4,105  
                 

 

On February 8, 2018, the Company entered into a preferred stock purchase agreement (“Stock Purchase Agreement”) with several accredited and institutional investors, pursuant to which the Company agreed to issue and sell in a private placement 1,950 shares of Series A Preferred Stock, as well as 975,000 warrants to purchase the Company’s common stock, at a purchase price of $1,000 per share, for total gross proceeds of $1.95 million (including previous advances from related parties). The warrants have a 5-year term and an exercise price of $2.00. Steven M. Payne converted $100,000, Jerome I. Feldman converted $50,000 and Jim Kilman through KielStrand Capital LLC converted $100,000 advances into preferred stock. Sam Pitroda through Pitroda Group LLC invested $500,000 and the Company issued 500 Series A Preferred Stock and 250,000 warrants on the same terms as other accredited and institutional investors.

 

The Series A Preferred is entitled to accrue cumulative dividends at a rate equal to 10.0% simple interest per annum on the original issue price of $1,000 per share (the “Original Issue Price”). Accrued dividends will be payable quarterly based on a 365-day year and may be paid in cash or in additional shares of Series A Preferred. Each share of Series A Preferred is convertible into 572 shares of Common Stock, subject to customary increases or decreases for stock splits, stock dividends recapitalizations and the like, and may be converted to Common Stock at any time after issuance at the option of a holder. The Company will have the right, at the Company’s option, to redeem all or a portion of the shares of Series A Preferred Stock at any time or times after the one year anniversary of the Issuance Date of such Series A Preferred Stock, at a price per share (the “Redemption Price”) equal to the sum of the following (without duplication): (a) the Original Issue Price, plus (b) any accrued but unpaid Dividends. Upon any liquidation, dissolution or winding up of the Company, liquidation of the Company’s assets will be made in the following order of priority: (a) first, payment or provision for payment of debts and other liabilities; (b) second, payment to the holders of Series A Preferred an amount with respect to each share of Series A Preferred equal to the Original Issue Price, plus any accrued but unpaid Dividends thereon; and (c) third, payment to the holders of Common Stock. Except as required by applicable law or as set forth herein, the holders of shares of Series A Preferred Stock will vote together with the holders of shares of Common Stock and not as a separate class. Each share of Series A Preferred Stock will have a number of votes equal to the number of shares of Common Stock then issuable upon conversion of such share of Series A Preferred Stock.

 

The Series A Preferred Stock is being classified as temporary equity because it has redemption features that are outside of the Company’s control upon certain triggering events, such as a deemed liquidation event. A “Deemed Liquidation Event” is defined in the Company’s Amended and Restated Certificate of Incorporation as a merger that results in a change in control or the sale of substantially all the assets of the Company. In the case of a Deemed Liquidation Event, the assets of the Company will be paid in order of liquidation preference to the holders of preferred and common stock. Because certain holders of the Series A Preferred Stock constitute a majority of the Company’s Board of Directors, a potential Deemed Liquidation Event is considered to be outside the control of the Company along with the call provision that can be exercised in one year, resulting in classification of the Series A Preferred Stock as temporary equity.

 

The Company has determined that the warrants should be accounted as a component of stockholders’ equity. On the issuance date, the Company estimated the fair value of the warrants at $1.2 million using the Black-Scholes option pricing model using the following primary assumptions: contractual term of 5.0 years, volatility rate of 74.8%, risk-free interest rate of 2.57% and expected dividend rate of 0%. Based on the warrant’s relative fair value to the fair value of the Series A Preferred, approximately $687,000 of the $1.2 million of aggregate fair value was allocated to the warrants, creating a corresponding preferred stock discount in the same amount.

 

Due to the reduction of allocated proceeds to Series A Preferred, the effective conversion price was approximately $1.13 per share creating a beneficial conversion feature of $956,000 which reduced the carrying value of the Series A Preferred. Since the conversion option of the Series A Preferred was immediately exercisable, the beneficial conversion feature was immediately accreted to preferred dividends, resulting in an increase in the carrying value of the Series A Preferred.

 

During nine months ended September 30, 2018, there were 55 shares of preferred stock converted into 31,460 shares of common stock. As of September 30, 2018, the dividends accrued and outstanding were $385,000 and reflected in carrying value of temporary equity.

XML 23 R14.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' (Deficit) Equity
9 Months Ended
Sep. 30, 2018
Equity [Abstract]  
Stockholders' (Deficit) Equity

Note 7 - Stockholders’ (Deficit) Equity

 

Common Stock

 

On March 21, 2018, the Company entered into a private placement offering with an investor and issued 826,446 shares of its common stock for $1.0 million. In addition, the Company granted this investor the non-exclusive rights to distribute its product in China for a period of two years. In connection with this private placement, the Company issued 41,322 shares of common stock to an investor as a finder’s fee.

 

On August 23, 2018, the Company entered into a private placement offering with three investors and issued 666,665 shares of its common stock for $800,000.

 

Stock Options

 

The fair value of the Company’s common stock was based upon the publicly quoted price on the date that the final approval of the awards was obtained. The Company does not expect to pay dividends in the foreseeable future so therefore the expected dividend yield is 0%. The expected term for stock options granted with service conditions represents the average period the stock options are expected to remain outstanding and is based on the expected term calculated using the approach prescribed by the Securities and Exchange Commission’s Staff Accounting Bulletin for “plain vanilla” options. The expected term for stock options granted with performance and/or market conditions represents the period estimated by management by which the performance conditions will be met. The Company obtained the risk-free interest rate from publicly available data published by the Federal Reserve. The Company uses a methodology in estimating its volatility percentage from a computation that was based on a comparison of average volatility rates of similar companies to a computation based on the standard deviation of the Company’s own underlying stock price’s daily logarithmic returns. The grant date fair value of stock options granted during the nine months ended September 30, 2018 and 2017 was $8.4 million and $4.6 million, respectively. The fair value of options granted during the nine months ended September 30, 2018 and 2017 were estimated using the following weighted-average assumptions:

 

    For the Nine Months Ended September 30,  
    2018     2017  
Exercise price   $ 2.05     $ 1.85  
Expected stock price volatility     78 %     79 %
Risk-free rate of interest     2.68 %     1.61 %
Term (years)     4.0       3.1  

 

A summary of option activity under the Company’s employee stock option plan for the nine months ended September 30, 2018 is presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2017     5,669,000     $ 1.48     $ 7,793,000       4.3  
Employee options granted     7,610,000       2.06       19,000       6.5  
Exercised     (100,000 )     0.20       152,000       -  
Expired     (250,000 )     0.10       443,000       -  
Outstanding as of September 30, 2018     12,929,000     $ 1.85     $ 1,649,000       5.4  
Options vested and expected to vest as of September 30, 2018     12,929,000     $ 1.85     $ 1,649,000       5.4  
Options vested and exercisable as of September 30, 2018     3,336,500     $ 1.51     $ 1,185,000       3.9  

 

Estimated future stock-based compensation expense relating to unvested employee stock options is approximately $8.3 million as of September 30, 2018 and will be amortized over 4.0 years.

 

A summary of activity of options granted to non-employees for the nine months ended September 30, 2018 is presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2017     3,205,000     $ 0.40     $ 7,847,000       2.4  
Non-employee options granted     200,000       1.64       22,000       4.0  
Exercised     (10,000 )     0.20       22,000       -  
Expired     (300,000 )     0.15       491,000       -  
Outstanding as of September 30, 2018     3,095,000     $ 0.51     $ 3,767,000       2.0  
Options vested and expected to vest as of September 30, 2018     3,095,000     $ 0.51     $ 3,767,000       2.0  
Options vested and exercisable as of September 30, 2018     2,582,500     $ 0.47     $ 3,223,000       1.9  

 

 

Warrants

 

A summary of the status of the Company’s outstanding warrants as of September 30, 2018 and changes during the nine months then ended is presented below:

 

    Number of Warrants     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2017     4,744,292     $ 1.24     $ 7,884,000       3.6  
Issued     975,000       2.00       -       4.4  
Exercised     (1,000,000 )     0.20       1,680,000       -  
Outstanding as of September 30, 2018     4,719,292     $ 1.62     $ 1,830,000       3.3  
Warrants exercisable as of September 30, 2018     4,469,292     $ 1.64     $ 1,705,000       3.2  

 

Stock-based Compensation Expense

 

Stock-based compensation expense for the nine months ended September 30, 2018 and 2017 was comprised of the following (dollars in thousands):

 

    For the Three Months Ended September 30,     For the Nine Months Ended September 30,  
    2018     2017     2018     2017  
Employee stock option awards   $ 862     $ 1,367     $ 2,250     $ 1,723  
Non-employee option awards     (22 )     273       (318 )     983  
Total compensation expense   $ 840     $ 1,640     $ 1,932     $ 2,706  

XML 24 R15.htm IDEA: XBRL DOCUMENT v3.10.0.1
Significant and Critical Accounting Policies and Practices (Policies)
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Basis of Presentation and Principles of Consolidation

Basis of Presentation and Principles of Consolidation

 

On June 14, 2018 the Company completed the purchase all of the outstanding shares of CLC such that CLC became a wholly-owned subsidiary of the Company and was immediately thereafter merged with and into the Company, with the Company surviving. Accordingly, as of June 14, 2018 the Company no longer has any subsidiaries consolidated in these financial statements.

 

For the year ended December 31, 2017 and through June 14, 2018, the accompanying condensed consolidated financial statements include the accounts of the Company’s subsidiaries. For consolidated entities where the Company owns less than 100% of the subsidiary, the Company records net loss attributable to non-controlling interests in its condensed consolidated statements of operations equal to the percentage of the economic or ownership interest retained in such entities by the respective non-controlling parties.

 

The condensed consolidated balance at December 31, 2017 was derived from audited annual financial statements but do not contain all of the footnote disclosures from the annual financial statements. The unaudited condensed financial statements have been prepared by the Company pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”) and reflect all adjustments (consisting of normal recurring adjustments unless otherwise indicated) which, in the opinion of management, are necessary for a fair presentation of the results for the interim periods presented.

 

Certain information in footnote disclosures normally included in the financial statements prepared in conformity with accounting principles generally accepted in the United States of America have been condensed or omitted pursuant to the SEC rules and regulations for interim reporting. The financial results for the periods presented may not be indicative of the full year’s results.

 

These unaudited condensed financial statements should be read in conjunction with the Company’s audited consolidated financial statements and the notes thereto for the fiscal year ended December 31, 2017 included in the Company’s Annual Report on Form 10-K filed on April 2, 2018.

Use of Estimates

Use of Estimates

 

The Company’s condensed financial statements include certain amounts that are based on management’s best estimates and judgments. The Company’s significant estimates include, but are not limited to, useful lives assigned to long-lived assets, fair value used in estimating the value of warrants, stock-based compensation, accrued expenses and provisions for income taxes. Due to the uncertainty inherent in such estimates, actual results may differ from these estimates.

Cash

Cash

 

As of September 30, 2018 and December 31, 2017, substantially all of the Company’s cash was held by major financial institutions and the balance at certain times may exceed the maximum amount insured by the Federal Deposits Insurance Corporation. However, the Company has not experienced losses on these accounts and management believes that the Company is not exposed to significant risks on such accounts.

Property and Equipment

Property and Equipment

 

Lab equipment, leasehold improvements and office equipment are recorded at cost and depreciated using the straight-line method over the estimated useful life of each asset, generally three to seven years.

Impairment of Long-Lived Assets

Impairment of Long-Lived Assets

 

The Company reviews long-lived assets, including property and equipment, for impairment whenever events or changes in business circumstances indicate that the carrying amount of the assets may not be fully recoverable. Factors that the Company considers in deciding when to perform an impairment review include significant underperformance of the business in relation to expectations, significant negative industry or economic trends, and significant changes or planned changes in the use of the assets. If an impairment review is performed to evaluate a long-lived asset for recoverability, the Company compares forecasts of undiscounted cash flows expected to result from the use and eventual disposition of the long-lived asset to its carrying value. An impairment loss would be recognized when estimated undiscounted future cash flows expected to result from the use of an asset are less than its carrying amount. The impairment loss would be based on the excess of the carrying value of the impaired asset over its fair value. There were no indicators of impairment for long-lived assets during the nine months ended September 30, 2018.

Fair Value of Preferred Stock

Fair Value of Preferred Stock

 

The fair value of Preferred stock was estimated based upon equivalent common shares that Preferred Stock could have been converted into at the closing price on the purchase date.

Convertible Financial Instruments

Convertible Financial Instruments

 

The Company bifurcates conversion options from their host instruments and accounts for them as free standing derivative financial instruments if certain criteria are met. The criteria include circumstances in which (a) the economic characteristics and risks of the embedded derivative instrument are not clearly and closely related to the economic characteristics and risks of the host contract, (b) the hybrid instrument that embodies both the embedded derivative instrument and the host contract is not re-measured at fair value under otherwise applicable generally accepted accounting principles with changes in fair value reported in earnings as they occur and (c) a separate instrument with the same terms as the embedded derivative instrument would be considered a derivative instrument. An exception to this rule is when the host instrument is deemed to be conventional, as that term is described under applicable GAAP.

 

When the Company has determined that the embedded conversion options should not be bifurcated from their host instruments, discounts are recorded for the intrinsic value of conversion options embedded in the instruments based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the instrument. Deemed dividends are also recorded for the intrinsic value of conversion options embedded in preferred shares based upon the differences between the fair value of the underlying common stock at the commitment date of the transaction and the effective conversion price embedded in the preferred shares.

Research and Development

Research and Development

 

Research and development costs are expensed as incurred. Advance payments for goods and services that will be used in future research and development activities are expensed when the activity has been performed or when the goods have been received rather than when the payment is made. Upfront and milestone payments due to third parties that perform research and development services on the Company’s behalf will be expensed as services are rendered or when the milestone is achieved.

 

Research and development costs primarily consist of personnel related expenses, including salaries, benefits, travel, and other related expenses, stock-based compensation, payments made to third parties for license and milestone costs related to in-licensed products and technology, payments made to third party contract research organizations, consultants, the cost of acquiring and manufacturing research trial materials, and costs associated with regulatory filings, laboratory costs and other supplies.

 

In accordance with ASC 730-10-25-1, Research and Development, costs incurred in obtaining technology licenses are charged to research and development expense if the technology licensed has not reached commercial feasibility and has no alternative future use. Certain licenses purchased by the Company require substantial completion of research and development and regulatory and marketing approval efforts in order to reach commercial feasibility and have no alternative future use.

 

During the nine months ended September 30, 2018, in addition to ongoing efforts at one major research university, the Company entered into additional contracts with a national research lab and another major research university for additional work related to development and scale-up of the Company’s processes. The Company also commenced research and development efforts at the Company’s Yonkers lab facility.

Contingencies

Contingencies

 

The Company records accruals for contingencies and legal proceedings expected to be incurred in connection with a loss contingency when it is probable that a liability has been incurred and the amount can be reasonably estimated.

 

If a loss contingency is not probable but is reasonably possible, or is probable but cannot be estimated, the nature of the contingent liability, together with an estimate of the range of possible loss if determinable and material, would be disclosed.

Stock-Based Compensation

Stock-Based Compensation

 

The Company expenses stock-based compensation to employees over the requisite service period based on the estimated grant-date fair value of the awards. For stock-based compensation awards to non-employees, the Company remeasures the fair value of the non-employee awards at each reporting period prior to vesting and finally at the vesting date of the award. Changes in the estimated fair value of these non-employee awards are recognized as compensation expense in the period of change.

 

The Company estimates the fair value of stock options grants using the Black-Scholes option pricing model and the assumptions used in calculating the fair value of stock-based awards represent management’s best estimates and involve inherent uncertainties and the application of management’s judgment.

Income Taxes

Income Taxes

 

The Company records income taxes using the asset and liability method. Deferred income tax assets and liabilities are recognized for the future tax effects attributable to temporary differences between the financial statement carrying amounts of existing assets and liabilities and their respective income tax bases, and operating loss and tax credit carryforwards. The Company establishes a valuation allowance if it is more likely than not that the deferred tax assets will not be recovered based on an evaluation of objective verifiable evidence. For tax positions that are more likely than not of being sustained upon audit, the Company recognizes the largest amount of the benefit that is greater than 50% likely of being realized. For tax positions that are not more likely than not of being sustained upon audit, the Company does not recognize any portion of the benefit.

Loss Per Share

Loss Per Share

 

Basic loss per share of common stock is computed by dividing net loss attributable to common stockholders by the weighted average number of shares of common stock outstanding for the period. Diluted loss per share excludes the potential impact of common stock options, convertible preferred stock and outstanding common stock purchase warrants because their effect would be anti-dilutive.

 

Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows:

 

    As of September 30,  
    2018     2017  
Warrants to purchase common stock     4,719,292       4,744,292  
Options to purchase common stock     16,024,000       8,880,000  
Preferred stock convertible into common stock     2,348,060       -  
Total     23,091,352       13,624,292  

Non-Controlling Interests

Non-Controlling Interests

 

Non-controlling interests in consolidated entities represent the component of equity in consolidated entities held by third parties. Any change in ownership of a subsidiary while the controlling financial interest is retained is accounted for as an equity transaction between the controlling and non-controlling interests.

Recent Accounting Pronouncements

Recent Accounting Pronouncements

 

The Company considers the applicability and impact of all Accounting Standard Updates (“ASUs”). ASUs not discussed below were assessed and determined to be either not applicable or are expected to have minimal impact on our balance sheets or statements of operations.

 

In August 2018, the Financial Accounting Standards Board (“FASB”) issued ASU 2018-13, “Fair Value Measurement (Topic 820), – Disclosure Framework – Changes to the Disclosure Requirements for Fair Value Measurement,” which makes a number of changes meant to add, modify or remove certain disclosure requirements associated with the movement amongst or hierarchy associated with Level 1, Level 2 and Level 3 fair value measurements. This guidance is effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2019. Early adoption is permitted upon issuance of the update. The Company is still evaluating but does not expect the adoption of this guidance to have a material impact on its condensed Financial Statements.

 

In August 2018, the SEC adopted the final rule under SEC Release No. 33-10532, Disclosure Update and Simplification, amending certain disclosure requirements that were redundant, duplicative, overlapping, outdated or superseded. In addition, the amendments expanded the disclosure requirements on the analysis of stockholders’ equity for interim financial statements. Under the amendments, an analysis of changes in each caption of stockholders’ equity presented in the balance sheet must be provided in a note or separate statement. The analysis should present a reconciliation of the beginning balance to the ending balance of each period for which a statement of comprehensive income is required to be filed. This final rule is effective on November 5, 2018. The Company plans to adopt this change in Q1 2019.

 

In June 2018, the FASB issued ASU 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting”, which simplifies the accounting for share-based payments granted to nonemployees for goods and services. Under the ASU, most of the guidance on such payments to nonemployees would be aligned with the requirements for share-based payments granted to employees. The changes take effect for public companies for fiscal years starting after December 15, 2018, including interim periods within that fiscal year. For all other entities, the amendments are effective for fiscal years beginning after December 15, 2019, and interim periods within fiscal years beginning after December 15, 2020. Early adoption is permitted, but no earlier than an entity’s adoption date of Topic 606. We are still evaluating but expect the adoption of this pronouncement will eliminate significant fluctuation in stock based compensation expensed in the past due to awards to non-employees.

 

In July 2017, the FASB issued ASU 2017-11, Earnings Per Share (Topic 260), Distinguishing Liabilities from Equity (Topic 480) and Derivatives and Hedging (Topic 815): I. Accounting for Certain Financial Instruments with Down Round Features; II. Replacement of the Indefinite Deferral for Mandatorily Redeemable Financial Instruments of Certain Nonpublic Entities and Certain Mandatorily Redeemable Noncontrolling Interests with a Scope Exception, (ASU 2017-11). Part I of this update addresses the complexity of accounting for certain financial instruments with down round features. Down round features are features of certain equity-linked instruments (or embedded features) that result in the strike price being reduced on the basis of the pricing of future equity offerings. Current accounting guidance creates cost and complexity for entities that issue financial instruments (such as warrants and convertible instruments) with down round features that require fair value measurement of the entire instrument or conversion option. Part II of this update addresses the difficulty of navigating Topic 480, Distinguishing Liabilities from Equity, because of the existence of extensive pending content in the FASB Accounting Standards Codification. This pending content is the result of the indefinite deferral of accounting requirements about mandatorily redeemable financial instruments of certain nonpublic entities and certain mandatorily redeemable noncontrolling interests. The amendments in Part II of this update do not have an accounting effect. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2018. The Company is currently assessing the potential impact of adopting ASU 2017-11 on its financial statements and related disclosures.

 

In May 2017, the FASB issued ASU 2017-09, Compensation-Stock Compensation (Topic 718): Scope of Modification Accounting, (ASU 2017-09). ASU 2017-09 provides clarity and reduces both (1) diversity in practice and (2) cost and complexity when applying the guidance in Topic 718, to a change to the terms or conditions of a share-based payment award. The amendments in ASU 2017-09 should be applied prospectively to an award modified on or after the adoption date. This ASU is effective for fiscal years, and interim periods within those years, beginning after December 15, 2017. The Company adopted this ASU on January 1, 2018 and the adoption did not have a material impact on the Company’s financial position or results of operations.

 

In February 2016, the FASB issued ASU 2016-02, Leases (Topic 842) and subsequent amendments to the initial guidance: ASU 2017-13, ASU 2018-10 and ASU 2018-11 (collectively, Topic 842). Topic 842 requires companies to generally recognize on the balance sheet operating and financing lease liabilities and corresponding right-of-use assets. Topic 842 is effective for us in our first quarter of fiscal 2020, and earlier adoption is permitted. We are currently evaluating the impact of our pending adoption of Topic 842 on our consolidated financial statements. We currently expect that most of our operating lease commitments (see MD&A for commitments) will be subject to the new standard and recognized as operating lease liabilities and right-of-use assets upon our adoption of Topic 842, which will increase our total assets and total liabilities that we report relative to such amounts prior to adoption.

 

In July 2018, the FASB issued ASU 2018-10, Codification Improvements to Topic 842, Leases which clarifies, corrects or consolidates authoritative guidance issued in ASU 2016-02 and is effective upon adoption of ASU 2016-02. In July 2018, the FASB issued ASU 2018-11, Targeted Improvements, which provides an optional transition method that allows entities to elect to apply the standard prospectively at its effective date, versus recasting the prior periods presented. If elected, an entity would recognize a cumulative effect adjustment to the opening balance of retained earnings in the period of adoption. The Company is still evaluating the method of adopting the standard.

 

In August 2016, the FASB issued ASU 2016-15, Statement of Cash Flows - Classification of Certain Cash Receipts and Cash Payments, which addresses eight specific cash flow issues with the objective of reducing the existing diversity in practice in how certain cash receipts and cash payments are presented and classified in the statement of cash flows. The standard is effective for fiscal years beginning after December 15, 2017, including interim periods within those fiscal years. The Company adopted the standard as of January 1, 2018 and adoption did not have a material impact on its condensed statement of cash flows.

XML 25 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Significant and Critical Accounting Policies and Practices (Tables)
9 Months Ended
Sep. 30, 2018
Accounting Policies [Abstract]  
Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share

Securities that could potentially dilute loss per share in the future that were not included in the computation of diluted loss per share at September 30, 2018 and 2017 are as follows:

 

    As of September 30,  
    2018     2017  
Warrants to purchase common stock     4,719,292       4,744,292  
Options to purchase common stock     16,024,000       8,880,000  
Preferred stock convertible into common stock     2,348,060       -  
Total     23,091,352       13,624,292  

XML 26 R17.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment (Tables)
9 Months Ended
Sep. 30, 2018
Property, Plant and Equipment [Abstract]  
Schedule of Property and Equipment

The components of property and equipment as of September 30, 2018 and December 31, 2017, at cost are (dollars in thousands):

 

    Useful Life (Years)     September 30, 2018     December 31, 2017  
Lab equipment     3     $ 415     $ 173  
Office furniture and equipment     3       31       31  
Leasehold improvement     7       379       374  
Gross property and equipment             825       578  
Less: Accumulated depreciation and amortization             (160 )     (77 )
Property and equipment, net           $ 665     $ 501  

XML 27 R18.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions (Tables)
9 Months Ended
Sep. 30, 2018
Related Party Transactions [Abstract]  
Schedule of Stock Price and Volume Milestones

      For 20 consecutive business   Total option shares that
Common stock price     days, with average daily   become vested on satisfaction
closes at or above     volumn in excess of   of conditions
$ 3.00     20,000   2,000,000 (28.5%)
$ 6.00     40,000   4,000,000 (51.7%)
$ 11.00     60,000   7,000,000 (100.0%)

XML 28 R19.htm IDEA: XBRL DOCUMENT v3.10.0.1
Temporary Equity (Tables)
9 Months Ended
Sep. 30, 2018
Temporary Equity [Abstract]  
Schedule of Temporary Equity

The following table summarizes the Company’s Series A Preferred Stock activities for the nine months ended September 30, 2018 (dollars in thousands):

 

    Series A Preferred Stock  
    Shares     Amount  
Total temporary equity as of December 31, 2017     1,935     $ 1,935  
Sale of Series A preferred stock     1,700       1,700  
Conversion of advances into preferred stock     250       250  
Preferred stock converted to common stock     (55 )     (55 )
Beneficial conversion feature of Series A preferred stock     -       (956 )
Deemed dividends related to beneficial conversion feature of Series A preferred stock     -       956  
Accrued Series A dividends     275       275  
Deemed dividend on Series A preferred stock     -       687  
Fair Value of common stock warrant issued with Series A preferred stock     -       (687 )
Total temporary equity as of September 30, 2018     4,105     $ 4,105  

XML 29 R20.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' (Deficit) Equity (Tables)
9 Months Ended
Sep. 30, 2018
Schedule of Fair Value of Assumptions

The fair value of options granted during the nine months ended September 30, 2018 and 2017 were estimated using the following weighted-average assumptions:

 

    For the Nine Months Ended September 30,  
    2018     2017  
Exercise price   $ 2.05     $ 1.85  
Expected stock price volatility     78 %     79 %
Risk-free rate of interest     2.68 %     1.61 %
Term (years)     4.0       3.1  

Schedule of Warrants Outstanding

A summary of the status of the Company’s outstanding warrants as of September 30, 2018 and changes during the nine months then ended is presented below:

 

    Number of Warrants     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2017     4,744,292     $ 1.24     $ 7,884,000       3.6  
Issued     975,000       2.00       -       4.4  
Exercised     (1,000,000 )     0.20       1,680,000       -  
Outstanding as of September 30, 2018     4,719,292     $ 1.62     $ 1,830,000       3.3  
Warrants exercisable as of September 30, 2018     4,469,292     $ 1.64     $ 1,705,000       3.2  

Schedule of Stock-based Compensation Expense

Stock-based compensation expense for the nine months ended September 30, 2018 and 2017 was comprised of the following (dollars in thousands):

 

    For the Three Months Ended September 30,     For the Nine Months Ended September 30,  
    2018     2017     2018     2017  
Employee stock option awards   $ 862     $ 1,367     $ 2,250     $ 1,723  
Non-employee option awards     (22 )     273       (318 )     983  
Total compensation expense   $ 840     $ 1,640     $ 1,932     $ 2,706  

Employee Stock Option Awards [Member]  
Schedule of Stock Options, Activity

A summary of option activity under the Company’s employee stock option plan for the nine months ended September 30, 2018 is presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2017     5,669,000     $ 1.48     $ 7,793,000       4.3  
Employee options granted     7,610,000       2.06       19,000       6.5  
Exercised     (100,000 )     0.20       152,000       -  
Expired     (250,000 )     0.10       443,000       -  
Outstanding as of September 30, 2018     12,929,000     $ 1.85     $ 1,649,000       5.4  
Options vested and expected to vest as of September 30, 2018     12,929,000     $ 1.85     $ 1,649,000       5.4  
Options vested and exercisable as of September 30, 2018     3,336,500     $ 1.51     $ 1,185,000       3.9  

Non-Employee Stock Option Awards [Member]  
Schedule of Stock Options, Activity

A summary of activity of options granted to non-employees for the nine months ended September 30, 2018 is presented below:

 

    Number of Shares     Weighted Average
Exercise Price
    Total Intrinsic Value     Weighted Average Remaining Contractual Life (in years)  
Outstanding as of December 31, 2017     3,205,000     $ 0.40     $ 7,847,000       2.4  
Non-employee options granted     200,000       1.64       22,000       4.0  
Exercised     (10,000 )     0.20       22,000       -  
Expired     (300,000 )     0.15       491,000       -  
Outstanding as of September 30, 2018     3,095,000     $ 0.51     $ 3,767,000       2.0  
Options vested and expected to vest as of September 30, 2018     3,095,000     $ 0.51     $ 3,767,000       2.0  
Options vested and exercisable as of September 30, 2018     2,582,500     $ 0.47     $ 3,223,000       1.9  

XML 30 R21.htm IDEA: XBRL DOCUMENT v3.10.0.1
Organization and Operations (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
24 Months Ended
Jun. 14, 2018
Dec. 31, 2016
Sep. 30, 2018
Feb. 08, 2018
Dec. 31, 2017
Mar. 29, 2017
Sep. 30, 2014
Franchisor Disclosure [Line Items]              
Equity ownership percentage 100.00%            
Common stock share authorized     57,000,000   57,000,000    
Common stock, par value     $ 0.01   $ 0.01    
Common Class B [Member]              
Franchisor Disclosure [Line Items]              
Common stock share authorized     1,000,000   1,000,000 1,000,000  
Common stock, par value       $ 0.01  
Series A Preferred [Member] | Minimum [Member]              
Franchisor Disclosure [Line Items]              
Preferred stock shares authorized       2,000      
Series A Preferred [Member] | Maximum [Member]              
Franchisor Disclosure [Line Items]              
Preferred stock shares authorized       5,000      
Board of Directors [Member]              
Franchisor Disclosure [Line Items]              
Issued and outstanding voting stock, percentage           75.00%  
Capital stock authorized           60,000,000  
Common stock share authorized           57,000,000  
Common stock, par value           $ 0.01  
Preferred stock shares authorized           2,000,000  
Preferred stock, par value           $ 0.01  
Clean Lithium Corporation [Member]              
Franchisor Disclosure [Line Items]              
Capital             $ 100
Equity ownership percentage   9.05%          
Number of common stock issued, shares 3,018,190 905,000          
XML 31 R22.htm IDEA: XBRL DOCUMENT v3.10.0.1
Going Concern and Liquidity (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]          
Accumulated deficit $ 24,719   $ 24,719   $ 20,276
Net loss $ 1,689 $ 2,440 4,598 $ 4,752  
Net cash used in operating activities     $ 3,018 $ 1,610  
XML 32 R23.htm IDEA: XBRL DOCUMENT v3.10.0.1
Significant and Critical Accounting Policies and Practices (Details Narrative) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Jun. 14, 2018
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Ownership percentage     100.00%
Impairment for long-lived assets    
Increase in prepaid expenses $ (2)  
Minimum [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Estimated useful life 3 years    
Maximum [Member]      
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]      
Estimated useful life 7 years    
XML 33 R24.htm IDEA: XBRL DOCUMENT v3.10.0.1
Significant and Critical Accounting Policies and Practices - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) - shares
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Franchisor Disclosure [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 23,091,352 13,624,292
Stock Option [Member]    
Franchisor Disclosure [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 16,024,000 8,880,000
Preferred Stock Convertible into Common Stock [Member]    
Franchisor Disclosure [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 2,348,060
Warrants to Purchase Common Stock [Member]    
Franchisor Disclosure [Line Items]    
Antidilutive securities excluded from computation of earnings per share, amount 4,719,292 4,744,292
XML 34 R25.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment (Details Narrative) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Property, Plant and Equipment [Abstract]        
Depreciation and amortization $ 32 $ 24 $ 83 $ 41
XML 35 R26.htm IDEA: XBRL DOCUMENT v3.10.0.1
Property and Equipment - Schedule of Property and Equipment (Details) - USD ($)
$ in Thousands
9 Months Ended
Sep. 30, 2018
Dec. 31, 2017
Property, Plant and Equipment [Line Items]    
Gross property and equipment $ 825 $ 578
Less: Accumulated depreciation and amortization (160) (77)
Property and equipment, net $ 665 501
Lab Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, useful life 3 years  
Gross property and equipment $ 415 173
Office Furniture and Equipment [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, useful life 3 years  
Gross property and equipment $ 31 31
Leasehold Improvement [Member]    
Property, Plant and Equipment [Line Items]    
Property, plant and equipment, useful life 7 years  
Gross property and equipment $ 379 $ 374
XML 36 R27.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
1 Months Ended 3 Months Ended 9 Months Ended
Feb. 08, 2018
Sep. 01, 2017
May 31, 2018
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Dec. 31, 2017
Related Party Transaction [Line Items]                
Advances from related parties       $ 36   $ 36   $ 308
Repayments of related party debt           22 $ 42  
Share based compensation       840 $ 1,640 1,932 $ 2,706  
Stock Option [Member]                
Related Party Transaction [Line Items]                
Share based compensation       466   $ 622    
Stock Option One [Member]                
Related Party Transaction [Line Items]                
Share based compensation       $ 210        
Valuation Technique, Option Pricing Model [Member] | Risk Free Interest Rate [Member]                
Related Party Transaction [Line Items]                
Fair value assumptions, measurement input, percentages       2.70%   2.70%    
Valuation Technique, Option Pricing Model [Member] | Volatility [Member]                
Related Party Transaction [Line Items]                
Fair value assumptions, measurement input, percentages       78.00%   78.00%    
Valuation Technique, Option Pricing Model [Member] | Expected Term [Member]                
Related Party Transaction [Line Items]                
Fair value assumptions, measurement input, term           4 years    
Valuation Technique, Option Pricing Model [Member] | Dividend Yield [Member]                
Related Party Transaction [Line Items]                
Fair value assumptions, measurement input, percentages       0.00%   0.00%    
Preferred Stock [Member]                
Related Party Transaction [Line Items]                
Conversion into stock           $ 250    
Jerome I. Feldman [Member]                
Related Party Transaction [Line Items]                
Repayments of related party debt           15    
Conversion into stock $ 50              
Steven M. Fludder [Member]                
Related Party Transaction [Line Items]                
Repayments of related party debt           7    
Mr. Pitroda [Member]                
Related Party Transaction [Line Items]                
Stock option to purchase common stock     7,000,000          
Exercise price per share     $ 2.08          
Share based compensation option expires in period     7 years          
Mr. Pitroda [Member] | Employment Agreement [Member]                
Related Party Transaction [Line Items]                
Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Grant Date Fair Value           $ 7,600    
Amortize option over its service period           4 years 1 month 2 days    
Share based compensation           $ 7,629    
Steven Fludder [Member]                
Related Party Transaction [Line Items]                
Number of shares under vested options were forfeited   150,000            
XML 37 R28.htm IDEA: XBRL DOCUMENT v3.10.0.1
Related Party Transactions - Schedule of Stock Price and Volume Milestones (Details)
9 Months Ended
Sep. 30, 2018
$ / shares
shares
Stock Option One [Member]  
Common stock price closes at or above | $ / shares $ 3.00
For 20 consecutive business days, with average daily volume in excess of 20,000
Total option shares that become vested on satisfaction of conditions 2,000,000
Total option shares that become vested on satisfaction of conditions, vesting percentage 28.50%
Stock Option Two [Member]  
Common stock price closes at or above | $ / shares $ 6.00
For 20 consecutive business days, with average daily volume in excess of 40,000
Total option shares that become vested on satisfaction of conditions 4,000,000
Total option shares that become vested on satisfaction of conditions, vesting percentage 51.70%
Stock Option Three [Member]  
Common stock price closes at or above | $ / shares $ 11.00
For 20 consecutive business days, with average daily volume in excess of 60,000
Total option shares that become vested on satisfaction of conditions 7,000,000
Total option shares that become vested on satisfaction of conditions, vesting percentage 100.00%
XML 38 R29.htm IDEA: XBRL DOCUMENT v3.10.0.1
Temporary Equity (Details Narrative) - USD ($)
$ / shares in Units, $ in Thousands
9 Months Ended
Feb. 08, 2018
Sep. 30, 2018
Valuation Technique, Option Pricing Model [Member] | Contractual Term [Member]    
Fair value assumptions, measurement input, term   4 years
Valuation Technique, Option Pricing Model [Member] | Volatility [Member]    
Fair value assumptions, measurement input, percentages   78.00%
Valuation Technique, Option Pricing Model [Member] | Risk Free Interest Rate [Member]    
Fair value assumptions, measurement input, percentages   2.70%
Valuation Technique, Option Pricing Model [Member] | Dividend Yield [Member]    
Fair value assumptions, measurement input, percentages   0.00%
Other Accredited and Institutional Investors [Member]    
Warrant purchase of common stock, shares 250,000  
Pitroda Group LLC [Member]    
Invested amount $ 500  
Steven M. Payne [Member]    
Number of preferred stock converted into shares of common stock 100  
Jerome I. Feldman [Member]    
Number of preferred stock converted into shares of common stock 50  
Jim Kilman [Member] | KielStrand Capital LLC [Member]    
Number of preferred stock converted into shares of common stock $ 100  
Series A Preferred Stock [Member]    
Number of preferred stock shares issue 1,950  
Warrant purchase of common stock, shares 975,000  
Purchase price per share $ 1  
Gross proceeds from issuance of preferred stock $ 1,950  
Warrants term 5 years  
Warrants exercise price $ 2.00  
Preferred stock shares issued 500  
Preferred stock dividend rate 10.00%  
Original issue price $ 1  
Number of common stock issued, shares 572 (55)
Warrants fair value $ 1,200  
Preferred stock fair value $ 687  
Preferred stock conversion basis Due to the reduction of allocated proceeds to Series A Preferred, the effective conversion price was approximately $1.13 per share  
Preferred stock beneficial conversion feature $ 956  
Series A Preferred Stock [Member] | Valuation Technique, Option Pricing Model [Member] | Contractual Term [Member]    
Fair value assumptions, measurement input, term 5 years  
Series A Preferred Stock [Member] | Valuation Technique, Option Pricing Model [Member] | Volatility [Member]    
Fair value assumptions, measurement input, percentages 74.80%  
Series A Preferred Stock [Member] | Valuation Technique, Option Pricing Model [Member] | Risk Free Interest Rate [Member]    
Fair value assumptions, measurement input, percentages 2.57%  
Series A Preferred Stock [Member] | Valuation Technique, Option Pricing Model [Member] | Dividend Yield [Member]    
Fair value assumptions, measurement input, percentages 0.00%  
Series A Preferred Stock [Member]    
Number of common stock issued, shares   31,460
Number of preferred stock converted into shares of common stock, shares   55
Dividend accrued and outstanding   $ 385
XML 39 R30.htm IDEA: XBRL DOCUMENT v3.10.0.1
Temporary Equity - Schedule of Temporary Equity (Details) - USD ($)
$ in Thousands
9 Months Ended
Feb. 08, 2018
Sep. 30, 2018
Preferred stock converted to common stock   $ 55
Accrued Series A dividends   $ (275)
Series A Preferred Stock [Member]    
Total temporary equity, shares beginning   1,935
Total temporary equity, beginning   $ 1,935
Sale of Series A preferred stock, shares   1,700
Sale of Series A preferred stock   $ 1,700
Conversion of advances into preferred stock, shares   250
Conversion of advances into preferred stock   $ 250
Preferred stock converted to common stock, shares 572 (55)
Preferred stock converted to common stock   $ (55)
Beneficial conversion feature of Series A preferred stock   (956)
Deemed dividends related to beneficial conversion feature of Series A preferred stock   $ 956
Accrued Series A dividends, shares   275
Accrued Series A dividends   $ 275
Deemed dividend on Series A preferred stock   687
Fair Value of common stock warrant issued with Series A preferred stock   $ (687)
Total temporary equity, shares ending   4,105
Total temporary equity, ending   $ 4,105
XML 40 R31.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' (Deficit) Equity (Details Narrative) - USD ($)
$ in Thousands
9 Months Ended
Aug. 23, 2018
Sep. 30, 2018
Sep. 30, 2017
Issuance of common stock for cash in a private placement   $ 1,800  
Stock Options [Member]      
Fair value of stock option granted   $ 8,400 $ 4,600
Unvested Employee Stock Options [Member]      
Amortized period   4 years 3 months 19 days  
Valuation Technique, Option Pricing Model [Member] | Dividend Yield [Member]      
Fair value assumptions, measurement input, percentages   0.00%  
Investor [Member]      
Issuance of common stock for cash in a private placement, shares   41,322  
Private Placement [Member]      
Issuance of common stock for cash in a private placement, shares 666,665 826,446  
Issuance of common stock for cash in a private placement $ 800 $ 1,000  
XML 41 R32.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' (Deficit) Equity - Schedule of Fair Value of Assumptions (Details) - $ / shares
9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Equity [Abstract]    
Exercise price $ 2.05 $ 1.85
Expected stock price volatility 78.00% 79.00%
Risk-free rate of interest 2.68% 1.61%
Term (years) 4 years 3 years 1 month 6 days
XML 42 R33.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' (Deficit) Equity - Schedule of Stock Options, Activity (Details)
9 Months Ended
Sep. 30, 2018
USD ($)
$ / shares
shares
Weighted Average Exercise Price, Outstanding, Ending Balance $ 2.05
Employee Stock Option Awards [Member]  
Number of Shares, Outstanding, Beginning Balance | shares 5,669,000
Number of Shares, Options granted | shares 7,610,000
Number of Shares, Options Exercised | shares (100,000)
Number of Shares, Expired | shares (250,000)
Number of Shares, Outstanding, Ending Balance | shares 12,929,000
Number of Shares, Options vested and expected to vest | shares 12,929,000
Number of Shares, Options vested and exercisable | shares 3,336,500
Weighted Average Exercise Price, Outstanding, Beginning Balance $ 1.48
Weighted Average Exercise Price, Options granted 2.06
Weighted Average Exercise Price, Options Exercised 0.20
Weighted Average Exercise Price, Expired 0.10
Weighted Average Exercise Price, Outstanding, Ending Balance 1.85
Weighted Average Exercise Price, Options vested and expected to vest 1.85
Weighted Average Exercise Price, Options vested and exercisable $ 1.51
Intrinsic Value, Outstanding, Beginning Balance | $ $ 7,793,000
Intrinsic Value, Options granted | $ 19,000
Intrinsic Value, Options exercised | $ 152,000
Intrinsic Value, Options expired | $ 443,000
Intrinsic Value, Outstanding, Ending Balance | $ 1,649,000
Intrinsic Value, Options vested and expected to vest | $ 1,649,000
Intrinsic Value, Options vested and exercisable | $ $ 1,185,000
Weighted Average Remaining Contractual Life (in years), Outstanding, Beginning Balance 4 years 3 months 19 days
Weighted Average Remaining Contractual Life (in years), Options granted 6 years 6 months
Weighted Average Remaining Contractual Life (in years), Options Exercised 0 years
Weighted Average Remaining Contractual Life (in years), Options Expired 0 years
Weighted Average Remaining Contractual Life (in years), Outstanding, Ending Balance 5 years 4 months 24 days
Weighted Average Remaining Contractual Life (in years), Options vested and expected to vest 5 years 4 months 24 days
Weighted Average Remaining Contractual Life (in years), Options vested and exercisable 3 years 10 months 25 days
Non-Employee Stock Option Awards [Member]  
Number of Shares, Outstanding, Beginning Balance | shares 3,205,000
Number of Shares, Options granted | shares 200,000
Number of Shares, Options Exercised | shares (10,000)
Number of Shares, Expired | shares (300,000)
Number of Shares, Outstanding, Ending Balance | shares 3,095,000
Number of Shares, Options vested and expected to vest | shares 3,095,000
Number of Shares, Options vested and exercisable | shares 2,582,500
Weighted Average Exercise Price, Outstanding, Beginning Balance $ 0.40
Weighted Average Exercise Price, Options granted 1.64
Weighted Average Exercise Price, Options Exercised 0.20
Weighted Average Exercise Price, Expired 0.15
Weighted Average Exercise Price, Outstanding, Ending Balance 0.51
Weighted Average Exercise Price, Options vested and expected to vest 0.51
Weighted Average Exercise Price, Options vested and exercisable $ 0.47
Intrinsic Value, Outstanding, Beginning Balance | $ $ 7,847,000
Intrinsic Value, Options granted | $ 22,000
Intrinsic Value, Options exercised | $ 22,000
Intrinsic Value, Options expired | $ 491,000
Intrinsic Value, Outstanding, Ending Balance | $ 3,767,000
Intrinsic Value, Options vested and expected to vest | $ 3,767,000
Intrinsic Value, Options vested and exercisable | $ $ 3,223,000
Weighted Average Remaining Contractual Life (in years), Outstanding, Beginning Balance 2 years 4 months 24 days
Weighted Average Remaining Contractual Life (in years), Options granted 4 years
Weighted Average Remaining Contractual Life (in years), Options Exercised 0 years
Weighted Average Remaining Contractual Life (in years), Options Expired 0 years
Weighted Average Remaining Contractual Life (in years), Outstanding, Ending Balance 2 years
Weighted Average Remaining Contractual Life (in years), Options vested and expected to vest 2 years
Weighted Average Remaining Contractual Life (in years), Options vested and exercisable 1 year 10 months 25 days
XML 43 R34.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' (Deficit) Equity - Schedule of Warrants Outstanding (Details) - Warrants to Purchase Common Stock [Member]
9 Months Ended
Sep. 30, 2018
USD ($)
$ / shares
shares
Number of Warrant, Beginning | shares 4,744,292
Number of Warrant, Issued | shares 975,000
Number of Warrant, Exercised | shares (1,000,000)
Number of Warrant, Ending | shares 4,719,292
Number of Warrants, Warrants exercisable | shares 4,469,292
Weighted Average Exercise Price, Outstanding, Beginning Balance | $ / shares $ 1.24
Weighted Average Exercise Price, Issued | $ / shares 2.00
Weighted Average Exercise Price, Exercised | $ / shares 0.20
Weighted Average Exercise Price, Outstanding, Ending Balance | $ / shares 1.62
Weighted Average Exercise Price, Warrants exercisable | $ / shares $ 1.64
Intrinsic Value, Outstanding, Beginning Balance | $ $ 7,884,000
Intrinsic Value, Issued | $
Intrinsic Value, Exercised | $ 1,680,000
Intrinsic Value, Outstanding, Ending Balance | $ 1,830,000
Intrinsic Value, Warrants exercisable | $ $ 1,705,000
Weighted Average Remaining Contractual Life (in years), Outstanding, Beginning Balance 3 years 7 months 6 days
Weighted Average Remaining Contractual Life (in years), Issued 4 years 4 months 24 days
Weighted Average Remaining Contractual Life (in years), Exercised 0 years
Weighted Average Remaining Contractual Life (in years), Outstanding, Ending Balance 3 years 3 months 19 days
Weighted Average Remaining Contractual Life (in years), Warrants exercisable 3 years 2 months 12 days
XML 44 R35.htm IDEA: XBRL DOCUMENT v3.10.0.1
Stockholders' (Deficit) Equity - Schedule of Stock-based Compensation Expense (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2018
Sep. 30, 2017
Sep. 30, 2018
Sep. 30, 2017
Share-based Compensation $ 840 $ 1,640 $ 1,932 $ 2,706
Employee Stock Option Awards [Member]        
Share-based Compensation 862 1,367 2,250 1,723
Non-Employee Stock Option Awards [Member]        
Share-based Compensation $ (22) $ 273 $ (318) $ 983
EXCEL 45 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 47 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 49 FilingSummary.xml IDEA: XBRL DOCUMENT 3.10.0.1 html 108 232 1 false 48 0 false 4 false false R1.htm 00000001 - Document - Document and Entity Information Sheet http://alpha-encorp.com/role/DocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 00000002 - Statement - Condensed Balance Sheets Sheet http://alpha-encorp.com/role/BalanceSheets Condensed Balance Sheets Statements 2 false false R3.htm 00000003 - Statement - Condensed Balance Sheets (Parenthetical) Sheet http://alpha-encorp.com/role/BalanceSheetsParenthetical Condensed Balance Sheets (Parenthetical) Statements 3 false false R4.htm 00000004 - Statement - Condensed Statements of Operations (Unaudited) Sheet http://alpha-encorp.com/role/StatementsOfOperations Condensed Statements of Operations (Unaudited) Statements 4 false false R5.htm 00000005 - Statement - Condensed Statements of Operations (Unaudited) (Parenthetical) Sheet http://alpha-encorp.com/role/StatementsOfOperationsParenthetical Condensed Statements of Operations (Unaudited) (Parenthetical) Statements 5 false false R6.htm 00000006 - Statement - Condensed Statement of Stockholders' Deficit (Unaudited) Sheet http://alpha-encorp.com/role/StatementOfStockholdersDeficit Condensed Statement of Stockholders' Deficit (Unaudited) Statements 6 false false R7.htm 00000007 - Statement - Condensed Statements of Cash Flows (Unaudited) Sheet http://alpha-encorp.com/role/StatementsOfCashFlows Condensed Statements of Cash Flows (Unaudited) Statements 7 false false R8.htm 00000008 - Disclosure - Organization and Operations Sheet http://alpha-encorp.com/role/OrganizationAndOperations Organization and Operations Notes 8 false false R9.htm 00000009 - Disclosure - Going Concern and Liquidity Sheet http://alpha-encorp.com/role/GoingConcernAndLiquidity Going Concern and Liquidity Notes 9 false false R10.htm 00000010 - Disclosure - Significant and Critical Accounting Policies and Practices Sheet http://alpha-encorp.com/role/SignificantAndCriticalAccountingPoliciesAndPractices Significant and Critical Accounting Policies and Practices Notes 10 false false R11.htm 00000011 - Disclosure - Property and Equipment Sheet http://alpha-encorp.com/role/PropertyAndEquipment Property and Equipment Notes 11 false false R12.htm 00000012 - Disclosure - Related Party Transactions Sheet http://alpha-encorp.com/role/RelatedPartyTransactions Related Party Transactions Notes 12 false false R13.htm 00000013 - Disclosure - Temporary Equity Sheet http://alpha-encorp.com/role/TemporaryEquity Temporary Equity Notes 13 false false R14.htm 00000014 - Disclosure - Stockholders' (Deficit) Equity Sheet http://alpha-encorp.com/role/StockholdersDeficitEquity Stockholders' (Deficit) Equity Notes 14 false false R15.htm 00000015 - Disclosure - Significant and Critical Accounting Policies and Practices (Policies) Sheet http://alpha-encorp.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesPolicies Significant and Critical Accounting Policies and Practices (Policies) Policies http://alpha-encorp.com/role/SignificantAndCriticalAccountingPoliciesAndPractices 15 false false R16.htm 00000016 - Disclosure - Significant and Critical Accounting Policies and Practices (Tables) Sheet http://alpha-encorp.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesTables Significant and Critical Accounting Policies and Practices (Tables) Tables http://alpha-encorp.com/role/SignificantAndCriticalAccountingPoliciesAndPractices 16 false false R17.htm 00000017 - Disclosure - Property and Equipment (Tables) Sheet http://alpha-encorp.com/role/PropertyAndEquipmentTables Property and Equipment (Tables) Tables http://alpha-encorp.com/role/PropertyAndEquipment 17 false false R18.htm 00000018 - Disclosure - Related Party Transactions (Tables) Sheet http://alpha-encorp.com/role/RelatedPartyTransactionsTables Related Party Transactions (Tables) Tables http://alpha-encorp.com/role/RelatedPartyTransactions 18 false false R19.htm 00000019 - Disclosure - Temporary Equity (Tables) Sheet http://alpha-encorp.com/role/TemporaryEquityTables Temporary Equity (Tables) Tables http://alpha-encorp.com/role/TemporaryEquity 19 false false R20.htm 00000020 - Disclosure - Stockholders' (Deficit) Equity (Tables) Sheet http://alpha-encorp.com/role/StockholdersDeficitEquityTables Stockholders' (Deficit) Equity (Tables) Tables http://alpha-encorp.com/role/StockholdersDeficitEquity 20 false false R21.htm 00000021 - Disclosure - Organization and Operations (Details Narrative) Sheet http://alpha-encorp.com/role/OrganizationAndOperationsDetailsNarrative Organization and Operations (Details Narrative) Details http://alpha-encorp.com/role/OrganizationAndOperations 21 false false R22.htm 00000022 - Disclosure - Going Concern and Liquidity (Details Narrative) Sheet http://alpha-encorp.com/role/GoingConcernAndLiquidityDetailsNarrative Going Concern and Liquidity (Details Narrative) Details http://alpha-encorp.com/role/GoingConcernAndLiquidity 22 false false R23.htm 00000023 - Disclosure - Significant and Critical Accounting Policies and Practices (Details Narrative) Sheet http://alpha-encorp.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesDetailsNarrative Significant and Critical Accounting Policies and Practices (Details Narrative) Details http://alpha-encorp.com/role/SignificantAndCriticalAccountingPoliciesAndPracticesTables 23 false false R24.htm 00000024 - Disclosure - Significant and Critical Accounting Policies and Practices - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Sheet http://alpha-encorp.com/role/SignificantAndCriticalAccountingPoliciesAndPractices-ScheduleOfAntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareDetails Significant and Critical Accounting Policies and Practices - Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share (Details) Details 24 false false R25.htm 00000025 - Disclosure - Property and Equipment (Details Narrative) Sheet http://alpha-encorp.com/role/PropertyAndEquipmentDetailsNarrative Property and Equipment (Details Narrative) Details http://alpha-encorp.com/role/PropertyAndEquipmentTables 25 false false R26.htm 00000026 - Disclosure - Property and Equipment - Schedule of Property and Equipment (Details) Sheet http://alpha-encorp.com/role/PropertyAndEquipment-ScheduleOfPropertyAndEquipmentDetails Property and Equipment - Schedule of Property and Equipment (Details) Details 26 false false R27.htm 00000027 - Disclosure - Related Party Transactions (Details Narrative) Sheet http://alpha-encorp.com/role/RelatedPartyTransactionsDetailsNarrative Related Party Transactions (Details Narrative) Details http://alpha-encorp.com/role/RelatedPartyTransactionsTables 27 false false R28.htm 00000028 - Disclosure - Related Party Transactions - Schedule of Stock Price and Volume Milestones (Details) Sheet http://alpha-encorp.com/role/RelatedPartyTransactions-ScheduleOfStockPriceAndVolumeMilestonesDetails Related Party Transactions - Schedule of Stock Price and Volume Milestones (Details) Details 28 false false R29.htm 00000029 - Disclosure - Temporary Equity (Details Narrative) Sheet http://alpha-encorp.com/role/TemporaryEquityDetailsNarrative Temporary Equity (Details Narrative) Details http://alpha-encorp.com/role/TemporaryEquityTables 29 false false R30.htm 00000030 - Disclosure - Temporary Equity - Schedule of Temporary Equity (Details) Sheet http://alpha-encorp.com/role/TemporaryEquity-ScheduleOfTemporaryEquityDetails Temporary Equity - Schedule of Temporary Equity (Details) Details 30 false false R31.htm 00000031 - Disclosure - Stockholders' (Deficit) Equity (Details Narrative) Sheet http://alpha-encorp.com/role/StockholdersDeficitEquityDetailsNarrative Stockholders' (Deficit) Equity (Details Narrative) Details http://alpha-encorp.com/role/StockholdersDeficitEquityTables 31 false false R32.htm 00000032 - Disclosure - Stockholders' (Deficit) Equity - Schedule of Fair Value of Assumptions (Details) Sheet http://alpha-encorp.com/role/StockholdersDeficitEquity-ScheduleOfFairValueOfAssumptionsDetails Stockholders' (Deficit) Equity - Schedule of Fair Value of Assumptions (Details) Details http://alpha-encorp.com/role/StockholdersDeficitEquityTables 32 false false R33.htm 00000033 - Disclosure - Stockholders' (Deficit) Equity - Schedule of Stock Options, Activity (Details) Sheet http://alpha-encorp.com/role/StockholdersDeficitEquity-ScheduleOfStockOptionsActivityDetails Stockholders' (Deficit) Equity - Schedule of Stock Options, Activity (Details) Details http://alpha-encorp.com/role/StockholdersDeficitEquityTables 33 false false R34.htm 00000034 - Disclosure - Stockholders' (Deficit) Equity - Schedule of Warrants Outstanding (Details) Sheet http://alpha-encorp.com/role/StockholdersDeficitEquity-ScheduleOfWarrantsOutstandingDetails Stockholders' (Deficit) Equity - Schedule of Warrants Outstanding (Details) Details http://alpha-encorp.com/role/StockholdersDeficitEquityTables 34 false false R35.htm 00000035 - Disclosure - Stockholders' (Deficit) Equity - Schedule of Stock-based Compensation Expense (Details) Sheet http://alpha-encorp.com/role/StockholdersDeficitEquity-ScheduleOfStock-basedCompensationExpenseDetails Stockholders' (Deficit) Equity - Schedule of Stock-based Compensation Expense (Details) Details http://alpha-encorp.com/role/StockholdersDeficitEquityTables 35 false false All Reports Book All Reports alpe-20180930.xml alpe-20180930.xsd alpe-20180930_cal.xml alpe-20180930_def.xml alpe-20180930_lab.xml alpe-20180930_pre.xml http://fasb.org/srt/2018-01-31 http://xbrl.sec.gov/dei/2018-01-31 http://fasb.org/us-gaap/2018-01-31 true true ZIP 51 0001493152-18-016013-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001493152-18-016013-xbrl.zip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end